> trials = read.csv("clinical_trial.csv", stringsAsFactors=FALSE)
> max(nchar(trials$abstract))
[1] 3708
> sum(nchar(trials$abstract) == 0)
[1] 112
> which.min(nchar(trials$title))
[1] 1258
> corpusTitle = VCorpus(VectorSource(trials$title))
> 
> corpusTitle = tm_map(corpusTitle, content_transformer(tolower))
> 
> corpusTitle = tm_map(corpusTitle, removePunctuation)
> 
> corpusTitle = tm_map(corpusTitle, removeWords, stopwords("english"))
> 
> corpusTitle = tm_map(corpusTitle, stemDocument)
> 
> dtmTitle = DocumentTermMatrix(corpusTitle)
> 
> dtmTitle = removeSparseTerms(dtmTitle, 0.95)
> 
> dtmTitle = as.data.frame(as.matrix(dtmTitle))
> corpusAbstract = VCorpus(VectorSource(trials$Abstract))
> 
> corpusAbstract = tm_map(corpusAbstract, content_transformer(tolower))
> 
> corpusAbstract = tm_map(corpusAbstract, removePunctuation)
> 
> corpusAbstract = tm_map(corpusAbstract, removeWords, stopwords("english"))
> 
> corpusAbstract = tm_map(corpusAbstract, stemDocument)
> 
> dtmAbstract = DocumentTermMatrix(corpusAbstract)
> 
> dtmAbstract = removeSparseTerms(dtmAbstract, 0.95)
> 
> dtmAbstract = as.data.frame(as.matrix(dtmAbstract))
> csAbstract = colSums(dtmAbstract)
> 
> which.max(csAbstract)
integer(0)
> str(dtmAbstract)
'data.frame':   0 obs. of  0 variables
> str(dtmTitle)
'data.frame':   1860 obs. of  31 variables:
 $ adjuv          : num  0 0 0 0 0 0 0 0 1 0 ...
 $ advanc         : num  0 0 0 0 0 0 1 0 0 0 ...
 $ breast         : num  0 0 1 1 1 1 0 1 1 1 ...
 $ cancer         : num  1 0 1 1 1 1 0 1 1 2 ...
 $ chemotherapi   : num  0 0 0 0 1 1 0 0 0 0 ...
 $ clinic         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ combin         : num  0 0 0 0 1 0 1 0 0 0 ...
 $ compar         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ cyclophosphamid: num  0 0 0 1 0 0 0 0 0 0 ...
 $ docetaxel      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ doxorubicin    : num  0 0 0 0 0 0 0 0 0 0 ...
 $ earli          : num  0 0 1 1 0 0 0 1 0 0 ...
 $ effect         : num  0 0 0 0 1 0 0 1 0 1 ...
 $ group          : num  0 0 0 0 0 0 0 0 1 1 ...
 $ iii            : num  0 0 1 0 0 0 0 0 0 1 ...
 $ metastat       : num  0 0 0 0 1 0 0 0 0 0 ...
 $ patient        : num  0 0 0 0 1 0 1 0 1 1 ...
 $ phase          : num  0 0 1 1 0 0 0 0 0 1 ...
 $ plus           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ postmenopaus   : num  0 0 0 0 0 0 0 1 1 0 ...
 $ random         : num  0 0 1 1 1 0 0 0 0 1 ...
 $ randomis       : num  0 0 0 0 0 0 0 1 1 0 ...
 $ respons        : num  0 0 0 0 0 1 0 0 0 0 ...
 $ result         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ studi          : num  0 0 0 0 0 0 0 1 0 0 ...
 $ tamoxifen      : num  0 0 0 0 0 0 0 2 1 0 ...
 $ therapi        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ treatment      : num  1 0 0 0 1 0 0 0 0 1 ...
 $ trial          : num  0 0 1 1 1 0 0 1 1 1 ...
 $ versus         : num  0 0 1 0 0 0 0 1 0 0 ...
 $ women          : num  0 0 0 0 0 0 0 1 0 0 ...
> corpusAbstract = VCorpus(VectorSource(trials$Abstract))
> str(dtmTitle)
'data.frame':   1860 obs. of  31 variables:
 $ adjuv          : num  0 0 0 0 0 0 0 0 1 0 ...
 $ advanc         : num  0 0 0 0 0 0 1 0 0 0 ...
 $ breast         : num  0 0 1 1 1 1 0 1 1 1 ...
 $ cancer         : num  1 0 1 1 1 1 0 1 1 2 ...
 $ chemotherapi   : num  0 0 0 0 1 1 0 0 0 0 ...
 $ clinic         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ combin         : num  0 0 0 0 1 0 1 0 0 0 ...
 $ compar         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ cyclophosphamid: num  0 0 0 1 0 0 0 0 0 0 ...
 $ docetaxel      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ doxorubicin    : num  0 0 0 0 0 0 0 0 0 0 ...
 $ earli          : num  0 0 1 1 0 0 0 1 0 0 ...
 $ effect         : num  0 0 0 0 1 0 0 1 0 1 ...
 $ group          : num  0 0 0 0 0 0 0 0 1 1 ...
 $ iii            : num  0 0 1 0 0 0 0 0 0 1 ...
 $ metastat       : num  0 0 0 0 1 0 0 0 0 0 ...
 $ patient        : num  0 0 0 0 1 0 1 0 1 1 ...
 $ phase          : num  0 0 1 1 0 0 0 0 0 1 ...
 $ plus           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ postmenopaus   : num  0 0 0 0 0 0 0 1 1 0 ...
 $ random         : num  0 0 1 1 1 0 0 0 0 1 ...
 $ randomis       : num  0 0 0 0 0 0 0 1 1 0 ...
 $ respons        : num  0 0 0 0 0 1 0 0 0 0 ...
 $ result         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ studi          : num  0 0 0 0 0 0 0 1 0 0 ...
 $ tamoxifen      : num  0 0 0 0 0 0 0 2 1 0 ...
 $ therapi        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ treatment      : num  1 0 0 0 1 0 0 0 0 1 ...
 $ trial          : num  0 0 1 1 1 0 0 1 1 1 ...
 $ versus         : num  0 0 1 0 0 0 0 1 0 0 ...
 $ women          : num  0 0 0 0 0 0 0 1 0 0 ...
> str(dtmAbstract)
'data.frame':   0 obs. of  0 variables
> str(corpusAbstract)
 Named list()
 - attr(*, "class")= chr [1:2] "VCorpus" "Corpus"
> str(corpusTitle)
List of 1860
 $ 1   :List of 2
  ..$ content: chr "treatment hodgkin diseas cancer 13bis2chloroethyl1nitrosourea bcnu nsc409962"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "1"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 2   :List of 2
  ..$ content: chr "cell mediat immun status malignancypretherapi posttherapi assess"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "2"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 3   :List of 2
  ..$ content: chr "neoadjuv vinorelbinecapecitabin versus docetaxeldoxorubicincyclophosphamid earli nonrespons breast cancer phase"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "3"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 4   :List of 2
  ..$ content: chr "random phase 3 trial fluorouracil epirubicin cyclophosphamid alon follow paclitaxel earli breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "4"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 5   :List of 2
  ..$ content: chr "firstlin singleag mitoxantron treatment highrisk metastat breast cancer patient effect combin chemotherapi diff"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "5"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 6   :List of 2
  ..$ content: chr "express bcl2 nodeneg breast cancer associ various prognost factor predict respons one cours periop chemotherapi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "6"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 7   :List of 2
  ..$ content: chr "combin docetaxelcyclophosphamid patient advanc solid tumor"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "7"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 8   :List of 2
  ..$ content: chr "longterm endometri effect postmenopaus women earli breast cancer particip intergroup exemestan studi iesa rando"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "8"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 9   :List of 2
  ..$ content: chr "postop radiotherapi highrisk postmenopaus breastcanc patient given adjuv tamoxifen danish breast cancer cooper "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "9"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 10  :List of 2
  ..$ content: chr "mometason furoat effect acut skin toxic breast cancer patient receiv radiotherapi phase iii doubleblind random "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "10"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 11  :List of 2
  ..$ content: chr "adjuv therapi cancer via cellular immun mechan fibrin induc fibrinolysi oral anticoagul"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "11"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 12  :List of 2
  ..$ content: chr "highdos chemotherapi autolog stem cell rescu metastat breast cancer superior surviv tandem compar singl transplant"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "12"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 13  :List of 2
  ..$ content: chr "randomis pilot phase ii studi doxorubicin cyclophosphamid ac epirubicin cyclophosphamid ec given 2 week pegfilg"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "13"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 14  :List of 2
  ..$ content: chr "new pharmacolog develop treatment hepatocellular cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "14"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 15  :List of 2
  ..$ content: chr "role chemotherapeut drug evalu breast tumour respons chemotherapi use serial fdgpet"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "15"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 16  :List of 2
  ..$ content: chr "adjuv capecitabin docetaxel cyclophosphamid epirubicin earli breast cancer final analysi random finxx trial"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "16"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 17  :List of 2
  ..$ content: chr "surgic adjuv chemotherapi cancer breast result decad cooper investig"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "17"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 18  :List of 2
  ..$ content: chr "potenti respons chemotherapi patient breast cancer dietari supplement larginin result randomis control trial"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "18"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 19  :List of 2
  ..$ content: chr "result two random trial evalu adjuv anthracyclinebas chemotherapi 1146 patient earli breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "19"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 20  :List of 2
  ..$ content: chr "bazedoxifen select estrogen receptor modul effect endometrium ovari breast random control trial osteoporot postmenopaus women"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "20"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 21  :List of 2
  ..$ content: chr "patholog paramet adjuv tamoxifen respons randomis premenopaus breast cancer trial"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "21"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 22  :List of 2
  ..$ content: chr "random trial adjuv ovarian suppress 926 premenopaus patient earli breast cancer treat adjuv chemotherapi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "22"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 23  :List of 2
  ..$ content: chr "effect ad gefitinib neoadjuv chemotherapi estrogen receptor negat earli breast cancer random phase ii trial"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "23"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 24  :List of 2
  ..$ content: chr "increas 5î±reductas type 2 express human breast carcinoma follow aromatas inhibitor therapi correl decreas tumor cell prolifer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "24"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 25  :List of 2
  ..$ content: chr "fouryear followup trastuzumab plus adjuv chemotherapi oper human epiderm growth factor receptor 2posit breast c"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "25"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 26  :List of 2
  ..$ content: chr "role immunohistochem detect lymphnod metastas manag breast cancer intern breast cancer studi group"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "26"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 27  :List of 2
  ..$ content: chr "express sialyltn predict effect adjuv chemotherapi nodeposit breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "27"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 28  :List of 2
  ..$ content: chr "evalu risk factor predict nausea vomit current standardofcar antiemet treatment analysi phase 3 trial aprepit p"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "28"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 29  :List of 2
  ..$ content: chr "occurr stroke tamoxifen nsabp b24"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "29"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 30  :List of 2
  ..$ content: chr "effect tamoxifen mammograph densiti"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "30"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 31  :List of 2
  ..$ content: chr "patholog complet respons rate compar 3 versus 6 cycl epidoxorubicin docetaxel neoadjuv set patient stage ii iii breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "31"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 32  :List of 2
  ..$ content: chr "effect exemestan lipidem profil postmenopaus oper breast cancer patient follow 57 year adjuv tamoxifen prelimin"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "32"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 33  :List of 2
  ..$ content: chr "tamoxifen one year versus two year versus 6 month tamoxifen 6 month megestrol acet random comparison postmenopa"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "33"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 34  :List of 2
  ..$ content: chr "predict valu syndecan1 express respons neoadjuv chemotherapi primari breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "34"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 35  :List of 2
  ..$ content: chr "adjuv chemotherapi elder patient 70 year earli highrisk breast cancer retrospect analysi 260 patient"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "35"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 36  :List of 2
  ..$ content: chr "effect lmwh nadroparin tumor progress"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "36"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 37  :List of 2
  ..$ content: chr "phase ii clinic trial n4hydroxyphenylretinamid tamoxifen administr definit surgeri breast neoplasia"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "37"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 38  :List of 2
  ..$ content: chr "tango randomis phase iii trial gemcitabin paclitaxelcontain epirubicincyclophosphamidebas adjuv chemotherapi ea"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "38"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 39  :List of 2
  ..$ content: chr "protect effect highdos medroxyprogesteron acet hdmpa hematolog toxic induc chemotherapi advanc solid tumor mult"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "39"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 40  :List of 2
  ..$ content: chr "surgic complic skin spare mastectomi immedi prosthet reconstruct neoadjuv chemotherapi invas breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "40"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 41  :List of 2
  ..$ content: chr "docetaxel versus docetaxel altern gemcitabin treatment advanc breast cancer final analysi randomis trial"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "41"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 42  :List of 2
  ..$ content: chr "can breast mri predict axillari lymph node metastasi women undergo neoadjuv chemotherapi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "42"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 43  :List of 2
  ..$ content: chr "gene express profil breast cancer patient treat docetaxel doxorubicin cyclophosphamid within gepartrio trial he"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "43"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 44  :List of 2
  ..$ content: chr "evalu trastuzumab without chemotherapi postop adjuv therapi her2posit elder breast cancer patient random contro"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "44"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 45  :List of 2
  ..$ content: chr "patholog complet respons six compar three cycl neoadjuv epirubicin plus docetaxel granulocyt colonystimul facto"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "45"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 46  :List of 2
  ..$ content: chr "prospect multicent random phase iii studi week versus standard docetaxel plus doxorubicin d4 firstlin treatment"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "46"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 47  :List of 2
  ..$ content: chr "sustainedreleas metoclopramid plus methylprednisolon versus placebo plus methylprednisolon antiemet prophylaxi "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "47"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 48  :List of 2
  ..$ content: chr "prognost signific sialyltn antigen women treat breast carcinoma treat adjuv chemotherapi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "48"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 49  :List of 2
  ..$ content: chr "random control trial compar intrathec sustainedreleas cytarabin depocyt intrathec methotrex patient neoplast me"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "49"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 50  :List of 2
  ..$ content: chr "predict valu relat chang serum total sialic acid level respons neoadjuv chemotherapi patient local advanc breast carcinoma"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "50"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 51  :List of 2
  ..$ content: chr "prospect random trial thymopentin versus granulocytecoloni stimul factor without thymopentin prevent febril epi"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "51"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 52  :List of 2
  ..$ content: chr "kinet serum her2neu chang patient her2posit primari breast cancer initi primari chemotherapi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "52"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 53  :List of 2
  ..$ content: chr "random phase ii trial doxorubicin plus pemetrex follow docetaxel versus doxorubicin plus cyclophosphamid follow"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "53"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 54  :List of 2
  ..$ content: chr "primari breast cancer mammograph chang neoadjuv chemotherapi patholog correl"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "54"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 55  :List of 2
  ..$ content: chr "prospect randomis multicent trial singl fraction radiotherapi 8 gy x 1 versus multipl fraction 3 gy x 10 treatm"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "55"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 56  :List of 2
  ..$ content: chr "identifi patient high risk neutropen complic chemotherapi metastat breast cancer doxorubicin pegyl liposom doxo"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "56"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 57  :List of 2
  ..$ content: chr "vitamin e prophylaxi chemotherapyinduc neuropathi random control trial"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "57"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 58  :List of 2
  ..$ content: chr "dosedens adjuv chemotherapi nodeposit breast cancer docetaxel follow epirubicincyclophosphamid tec revers seque"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "58"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 59  :List of 2
  ..$ content: chr "prospect random trial evalu differ oral dose regimen medroxyprogesteron acet women advanc breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "59"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 60  :List of 2
  ..$ content: chr "biweek gemcitabinepaclitaxel gemcitabinecarboplatin gemcitabinecisplatin firstlin treatment metastat breast can"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "60"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 61  :List of 2
  ..$ content: chr "compar studi exemestan versus anastrozol patient postmenopaus breast cancer viscer metastas"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "61"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 62  :List of 2
  ..$ content: chr "random phase ii studi sequenti docetaxel doxorubicincyclophosphamid patient metastat breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "62"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 63  :List of 2
  ..$ content: chr "improv diseasefre surviv epirubicinbas chemoendocrin adjuv therapi compar tamoxifen alon one three nodeposit es"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "63"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 64  :List of 2
  ..$ content: chr "comparison differ approach assess her2 express protein mrna level predict chemotherapi respons neoadjuv gepartr"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "64"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 65  :List of 2
  ..$ content: chr "phase trial topic topitriol calcitriol 125dihydroxyvitamin d3 prevent chemotherapyinduc alopecia"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "65"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 66  :List of 2
  ..$ content: chr "cyclooxygenase2 inhibit improv reduct ductal carcinoma situ prolifer aromatas inhibitor therapi result erisac r"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "66"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 67  :List of 2
  ..$ content: chr "celecoxib exemestan versus placebo exemestan postmenopaus metastat breast cancer patient doubleblind phase iii gineco studi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "67"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 68  :List of 2
  ..$ content: chr "epirubicin paclitaxel gcsf support first line metastat breast cancer random phase ii studi dosedens doseescal chemotherapi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "68"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 69  :List of 2
  ..$ content: chr "delay chemotherapyinduc nausea augment high level endogen noradrenalin"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "69"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 70  :List of 2
  ..$ content: chr "evalu gmcsf mouthwash prevent chemotherapyinduc mucos random doubleblind doserang studi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "70"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 71  :List of 2
  ..$ content: chr "phase ii studi week albuminbound paclitaxel patient metastat breast cancer heavili pretreat taxan"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "71"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 72  :List of 2
  ..$ content: chr "establish histolog criteria highrisk nodeneg breast carcinoma multiinstitut random clinic trial adjuv therapi j"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "72"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 73  :List of 2
  ..$ content: chr "random phase ii trial week paclitaxel alon versus trastuzumab plus week paclitaxel firstlin therapi patient her"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "73"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 74  :List of 2
  ..$ content: chr "electrochemotherapi cisplatin cutan tumor lesion breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "74"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 75  :List of 2
  ..$ content: chr "random trial singl dose versus fraction palliat radiotherapi bone metastas"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "75"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 76  :List of 2
  ..$ content: chr "efficaci ibandron treatment skelet event patient metastat breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "76"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 77  :List of 2
  ..$ content: chr "relationship bone mass invas breast cancer incid raloxifen therapi postmenopaus women low bone mass osteoporosi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "77"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 78  :List of 2
  ..$ content: chr "predictor central nervous system metastasi patient metastat breast cancer compet risk analysi 579 patient treat"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "78"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 79  :List of 2
  ..$ content: chr "random clinic trial compar mitoxantron epirubicin doxorubicin combin cyclophosphamid firstlin treatment patient"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "79"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 80  :List of 2
  ..$ content: chr "phase iii studi highdos intensif without hematopoiet progenitor cell support patient highrisk primari breast carcinoma"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "80"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 81  :List of 2
  ..$ content: chr "randomis trial one cycl anthracyclinecontain adjuv chemotherapi compar six cycl cmf treatment nodeposit hormon "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "81"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 82  :List of 2
  ..$ content: chr "surgic procedur neoadjuv chemotherapi oper breast cancer result geparduo trial"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "82"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 83  :List of 2
  ..$ content: chr "salvag chemotherapi metastat breast cancer alway effect well toler phase ii random trial vinorelbin versus 5flu"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "83"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 84  :List of 2
  ..$ content: chr "xm02 superior placebo equival neupogen reduc durat sever neutropenia incid febril neutropenia cycl 1 breast can"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "84"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 85  :List of 2
  ..$ content: chr "phase iii pharmacokinet studi pemetrex epirubicin patient local advanc metastat breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "85"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 86  :List of 2
  ..$ content: chr "paclitaxel epirubicin firstlin therapi patient metastat breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "86"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 87  :List of 2
  ..$ content: chr "accuraci combin mammographi sonographi predict tumor respons breast cancer patient neoadjuv chemotherapi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "87"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 88  :List of 2
  ..$ content: chr "impact complementari mistleto extract treatment qualiti life breast ovarian nonsmal cell lung cancer patient pr"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "88"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 89  :List of 2
  ..$ content: chr "phase iii clinic trial alphadifluoromethylornithinean inhibitor polyamin biosynthesi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "89"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 90  :List of 2
  ..$ content: chr "effect differ dose cyclosporin system exposur oral administ paclitaxel"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "90"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 91  :List of 2
  ..$ content: chr "clinic trial mitoxantron novantron versus doxorubicin adriamycin combin chemotherapi metastat breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "91"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 92  :List of 2
  ..$ content: chr "mitoxantron fluorouracil lfolin acid anthracyclinepretr metastat breast cancer patient"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "92"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 93  :List of 2
  ..$ content: chr "incid invas breast cancer postmenopaus women discontinu longterm raloxifen administr"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "93"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 94  :List of 2
  ..$ content: chr "surgeri follow neoadjuv therapi patient her2posit local advanc inflammatori breast cancer particip neoadjuv her"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "94"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 95  :List of 2
  ..$ content: chr "longterm effect fenretinid retino acid deriv insulinlik growth factor system women earli breast cancer"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "95"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 96  :List of 2
  ..$ content: chr "evalu cooper clinic studi cytostat agent ifosfamid"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "96"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 97  :List of 2
  ..$ content: chr "local relaps primari breast cancer patient unexcis posit surgic margin lumpectomi radiotherapi chemoendocrin therapi"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "97"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 98  :List of 2
  ..$ content: chr "evalu 30gene paclitaxel fluorouracil doxorubicin cyclophosphamid chemotherapi respons predictor multicent rando"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "98"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 99  :List of 2
  ..$ content: chr "growth factor target ration applic intervent agent"
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:40:37"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "99"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
  [list output truncated]
 - attr(*, "class")= chr [1:2] "VCorpus" "Corpus"
> str(trials)
'data.frame':   1860 obs. of  3 variables:
 $ title   : chr  "Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962)." "Cell mediated immune status in malignancy--pretherapy and post-therapy assessment." "Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breas"| __truncated__ "Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for "| __truncated__ ...
 $ abstract: chr  "" "Twenty-eight cases of malignancies of different kinds were studied to assess T-cell activity and population bef"| __truncated__ "BACKGROUND: Among breast cancer patients, nonresponse to initial neoadjuvant chemotherapy is associated with un"| __truncated__ "BACKGROUND: Taxanes are among the most active drugs for the treatment of metastatic breast cancer, and, as a co"| __truncated__ ...
 $ trial   : int  1 0 1 1 1 0 1 0 0 0 ...
> corpusAbstract = VCorpus(VectorSource(trials$abstract))
> str(corpusAbstract)
List of 1860
 $ 1   :List of 2
  ..$ content: chr ""
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "1"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 2   :List of 2
  ..$ content: chr "Twenty-eight cases of malignancies of different kinds were studied to assess T-cell activity and population bef"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "2"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 3   :List of 2
  ..$ content: chr "BACKGROUND: Among breast cancer patients, nonresponse to initial neoadjuvant chemotherapy is associated with un"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "3"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 4   :List of 2
  ..$ content: chr "BACKGROUND: Taxanes are among the most active drugs for the treatment of metastatic breast cancer, and, as a co"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "4"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 5   :List of 2
  ..$ content: chr "BACKGROUND: To determine whether patients with high-risk metastatic breast cancer draw benefit from combination"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "5"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 6   :List of 2
  ..$ content: chr "The aim of this study was to assess relationships between Bcl-2 expression, response to chemotherapy and a numb"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "6"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 7   :List of 2
  ..$ content: chr "Preclinical studies show that docetaxel (Taxotere) and cyclophosphamide (Cytoxan, Neosar) are synergistic again"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "7"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 8   :List of 2
  ..$ content: chr "BACKGROUND: The antiestrogen tamoxifen may have partial estrogen-like effects on the postmenopausal uterus. Aro"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "8"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 9   :List of 2
  ..$ content: chr "BACKGROUND: Postmastectomy radiotherapy is associated with a lower locoregional recurrence rate and improved di"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "9"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 10  :List of 2
  ..$ content: chr "PURPOSE: A two-arm, double-blind, randomized trial was performed to evaluate the effect of 0.1% mometasone furo"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "10"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 11  :List of 2
  ..$ content: chr "The value of the oral anticoagulant warfarin sodium and fibrinolytic agents is discussed in relation to cancer "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "11"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 12  :List of 2
  ..$ content: chr "During 1990-1999, we treated 60 patients with breast cancer who had distant metastases with high-dose chemother"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "12"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 13  :List of 2
  ..$ content: chr "Accelerated (dose-dense) chemotherapy, in which the frequency of administration is increased without changing t"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "13"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 14  :List of 2
  ..$ content: chr "Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm and fourth leading cause of cancer dea"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "14"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 15  :List of 2
  ..$ content: chr "INTRODUCTION: The aims of this study were to investigate whether drug sequence (docetaxel followed by anthracyc"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "15"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 16  :List of 2
  ..$ content: chr "PURPOSE: Capecitabine is an active agent in the treatment of breast cancer. It is not known whether integration"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "16"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 17  :List of 2
  ..$ content: chr ""
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "17"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 18  :List of 2
  ..$ content: chr "Patients with large primary breast cancers are being treated with neo-adjuvant chemotherapy. Studies in animals"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "18"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 19  :List of 2
  ..$ content: chr "Two randomized trials evaluated the effect of 6 courses of anthracycline-based chemotherapy in early breast can"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "19"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 20  :List of 2
  ..$ content: chr "OBJECTIVE: The aim of this study was to evaluate the endometrial, ovarian, and breast safety of bazedoxifene us"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "20"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 21  :List of 2
  ..$ content: chr "BACKGROUND: Subgroups of breast cancer that have an impaired response to endocrine treatment, despite hormone r"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "21"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 22  :List of 2
  ..$ content: chr "PURPOSE: The aim of this multicenter trial was to evaluate the role of ovarian suppression in patients with ear"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "22"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 23  :List of 2
  ..$ content: chr "Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, has shown both anti-proliferative and"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "23"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 24  :List of 2
  ..$ content: chr "Tumor cell proliferation and progression of breast cancer are influenced by female sex steroids. However, not a"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "24"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 25  :List of 2
  ..$ content: chr "PURPOSE: Trastuzumab is a humanized monoclonal antibody against the human epidermal growth factor receptor 2 (H"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "25"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 26  :List of 2
  ..$ content: chr "BACKGROUND: This study was designed to ascertain whether immunohistochemical methods could improve the detectio"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "26"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 27  :List of 2
  ..$ content: chr "Sialyl-Tn (STn) is a carcinoma-associated carbohydrate determinant expressed on cancer-associated mucins and ha"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "27"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 28  :List of 2
  ..$ content: chr "GOALS OF WORK: A number of prognostic factors have been identified as risk factors for chemotherapy-induced eme"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "28"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 29  :List of 2
  ..$ content: chr ""
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "29"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 30  :List of 2
  ..$ content: chr "There are strong data showing that increased breast cancer risk is associated with increased mammographic densi"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "30"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 31  :List of 2
  ..$ content: chr "We conducted a prospective randomized study to compare the results of 3 cycles of epidoxorubicin/docetaxel to 6"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "31"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 32  :List of 2
  ..$ content: chr "Long-term endocrine therapy for breast cancer may have clinical implications as drugs that potentially alter th"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "32"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 33  :List of 2
  ..$ content: chr "From January 1, 1990 to December 31, 1994, DBCG conducted a randomised trial in 1 615 postmenopausal women with"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "33"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 34  :List of 2
  ..$ content: chr "BACKGROUND: The overexpression of syndecan-1 in breast carcinomas correlates with poorer prognosis and an aggre"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "34"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 35  :List of 2
  ..$ content: chr "BACKGROUND: Adjuvant chemotherapy in elderly women is currently perceived as one of the priorities in breast ca"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "35"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 36  :List of 2
  ..$ content: chr "Recent clinical studies on patients with malignancies, who were treated with UHF and LMWHs raised the possibili"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "36"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 37  :List of 2
  ..$ content: chr "PURPOSE: Surrogate end point biomarkers (SEBs) that can be measured in ductal carcinoma in situ or early-stage "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "37"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 38  :List of 2
  ..$ content: chr "tAnGo is a large randomised trial assessing the addition of gemcitabine(G) to paclitaxel(T), following epirubic"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "38"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 39  :List of 2
  ..$ content: chr "A multicenter, randomized, controlled trial was conducted comparing active treatment with placebo in 227 patien"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "39"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 40  :List of 2
  ..$ content: chr "BACKGROUND: Neoadjuvant chemotherapy is gaining acceptance as an option for breast cancer treatment, particular"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "40"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 41  :List of 2
  ..$ content: chr "BACKGROUND: Alternating administration of docetaxel and gemcitabine might result in improved time-to-treatment "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "41"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 42  :List of 2
  ..$ content: chr "BACKGROUND: Axillary lymph node status provides important staging information. We sought to evaluate the predic"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "42"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 43  :List of 2
  ..$ content: chr "Gene expression analysis in breast cancer patients undergoing neoadjuvant chemotherapy is an interesting tool f"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "43"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 44  :List of 2
  ..$ content: chr "OBJECTIVE: This trial is conducted to investigate the benefit of trastuzumab monotherapy compared with a combin"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "44"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 45  :List of 2
  ..$ content: chr "PURPOSE: Preoperative (neoadjuvant) chemotherapy for operable breast cancer downstages tumors initially not sui"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "45"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 46  :List of 2
  ..$ content: chr "PURPOSE: Previous phase II studies have indicated a greatly reduced hematotoxicity of docetaxel-based regimens "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "46"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 47  :List of 2
  ..$ content: chr "In a randomized double-blind cross-over trial, sustained-release metoclopramide (S) plus methylprednisolone (M)"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "47"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 48  :List of 2
  ..$ content: chr "BACKGROUND: Sialyl-Tn (STn) represents an aberrantly glycosylated mucin epitope that is expressed in breast car"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "48"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 49  :List of 2
  ..$ content: chr "Standard treatment for neoplastic meningitis requires frequent intrathecal (IT) injections of chemotherapy and "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "49"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 50  :List of 2
  ..$ content: chr "The aim of this study was to determine whether relative changes in total serum sialic acid (TSA) levels are ass"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "50"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 51  :List of 2
  ..$ content: chr "One hundred patients with advanced carcinoma undergoing highly cytotoxic chemotherapy were enrolled in a prospe"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "51"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 52  :List of 2
  ..$ content: chr "BACKGROUND: The purpose of the study was to determine the utility of quantitation of the extracellular domain ("| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "52"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 53  :List of 2
  ..$ content: chr "BACKGROUND: Neoadjuvant systemic therapy (NST) before surgery is a standard option for patients with early brea"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "53"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 54  :List of 2
  ..$ content: chr "PURPOSE: To correlate changes depicted at mammography during neo-adjuvant chemotherapy for operable breast carc"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "54"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 55  :List of 2
  ..$ content: chr "BACKGROUND AND PURPOSE: To investigate whether single-fraction radiotherapy is equal to multiple fractions in t"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "55"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 56  :List of 2
  ..$ content: chr "OBJECTIVE: To develop a cycle-based risk prediction model for neutropenic complications (NC) during chemotherap"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "56"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 57  :List of 2
  ..$ content: chr "BACKGROUND: The authors conducted a pilot, randomized, open label with blind assessment, controlled trial to de"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "57"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 58  :List of 2
  ..$ content: chr "BACKGROUND: Adding a taxane to anthracycline-based adjuvant chemotherapy prolongs survival in node-positive pat"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "58"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 59  :List of 2
  ..$ content: chr "A prospective randomized study was conducted to try to answer two questions: is a loading dose of medroxyproges"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "59"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 60  :List of 2
  ..$ content: chr "BACKGROUND: The primary objective of this multicenter, open-label, randomized, parallel, phase II selection tri"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "60"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 61  :List of 2
  ..$ content: chr "PURPOSE: Patients developing visceral breast cancer metastases generally receive chemotherapy rather than endoc"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "61"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 62  :List of 2
  ..$ content: chr "BACKGROUND: Docetaxel has yielded promising response rates as a component of doxorubicin-based combination sche"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "62"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 63  :List of 2
  ..$ content: chr "BACKGROUND: The purpose was to compare disease-free survival (DFS) between epirubicin-based chemoendocrine ther"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "63"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 64  :List of 2
  ..$ content: chr "Human epidermal growth factor receptor 2 (HER2) testing is an essential part of pathological assessment in brea"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "64"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 65  :List of 2
  ..$ content: chr "This study evaluated the toxicity and efficacy of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to p"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "65"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 66  :List of 2
  ..$ content: chr "PURPOSE: Tamoxifen reduces risk of recurrence after breast conservation surgery for ductal carcinoma in situ (D"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "66"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 67  :List of 2
  ..$ content: chr "The aim of this study was to evaluate antitumor effects of cyclooxygenase-2 inhibitors in breast carcinoma and "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "67"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 68  :List of 2
  ..$ content: chr "An increased dose-intensity can be achieved by either higher dose of chemotherapy per cycle (dose-escalation) o"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "68"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 69  :List of 2
  ..$ content: chr "The relation between pretreatment night-time urinary catecholamine excretion and chemotherapy-induced nausea an"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "69"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 70  :List of 2
  ..$ content: chr "Uncontrolled clinical trials have shown that parenteral administration of GM-CSF reduces the frequency of chemo"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "70"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 71  :List of 2
  ..$ content: chr "PURPOSE: Nanoparticle albumin-bound paclitaxel, a solvent-free, albumin-bound paclitaxel, demonstrated antitumo"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "71"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 72  :List of 2
  ..$ content: chr "BACKGROUND: A multi-institutional randomized clinical trial of adjuvant therapy for patients with high-risk nod"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "72"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 73  :List of 2
  ..$ content: chr "BACKGROUND: A randomized Phase II study evaluated the activity of weekly paclitaxel versus its combination with"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "73"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 74  :List of 2
  ..$ content: chr "We have evaluated the efficiency of electrochemotherapy with cisplatin on cutaneous tumor lesions of breast can"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "74"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 75  :List of 2
  ..$ content: chr "PURPOSE: Data in the literature suggest that for painful bone metastases a single dose is as effective as fract"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "75"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 76  :List of 2
  ..$ content: chr "Patients with breast carcinoma often develop bone metastases that carry a high risk of complications. A randomi"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "76"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 77  :List of 2
  ..$ content: chr "OBJECTIVE: To evaluate the relationship between bone mass and risk of breast cancer and to determine the effect"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "77"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 78  :List of 2
  ..$ content: chr "In order to identify factors predictive of central nervous system (CNS) metastasis, we reviewed the histories o"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "78"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 79  :List of 2
  ..$ content: chr "Two hundred and twenty-four patients with advanced breast cancer were enrolled in a multicenter prospective ran"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "79"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 80  :List of 2
  ..$ content: chr "Patients with more than nine ipsilateral lymph node involvement or inflammatory breast cancer have a 5-year sur"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "80"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 81  :List of 2
  ..$ content: chr "AIM: A randomised, controlled clinical trial was initiated in 1984 to test whether 1 cycle of anthracycline-con"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "81"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 82  :List of 2
  ..$ content: chr "BACKGROUND: Neoadjuvant chemotherapy can increase the rate of breast-conserving surgery in patients with operab"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "82"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 83  :List of 2
  ..$ content: chr "Metastatic breast cancer remains an incurable disease and the median overall survival has not significantly imp"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "83"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 84  :List of 2
  ..$ content: chr "BACKGROUND: Recombinant granulocyte colony-stimulating factors (G-CSFs) such as Filgrastim are used to treat ch"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "84"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 85  :List of 2
  ..$ content: chr "BACKGROUND: Pemetrexed and epirubicin are each active in patients with advanced/metastatic breast cancer (MBC)."| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "85"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 86  :List of 2
  ..$ content: chr "Paclitaxel (Taxol), has aroused considerable interest for its high single-agent activity in breast cancer and n"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "86"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 87  :List of 2
  ..$ content: chr "BACKGROUND: Residual tumor size after neoadjuvant chemotherapy is an important consideration in surgical planni"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "87"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 88  :List of 2
  ..$ content: chr "Standardized aqueous mistletoe extracts have been applied to cancer patients for several decades as complementa"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "88"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 89  :List of 2
  ..$ content: chr "Alpha-difluoromethylornithine (DFMO) is an enzyme-activated, irreversible inhibitor of ornithine decarboxylase,"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "89"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 90  :List of 2
  ..$ content: chr "The objective of this study was to define the minimally effective dose of cyclosporin A (CsA) that would result"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "90"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 91  :List of 2
  ..$ content: chr "Mitoxantrone (Novantrone, N) is a new anthracenedione derivative with structural similarities to doxorubicin (A"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "91"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 92  :List of 2
  ..$ content: chr "In this phase II trial we have evaluated the activity and toxicity of a combination regimen containing mitoxant"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "92"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 93  :List of 2
  ..$ content: chr "BACKGROUND: Postmenopausal women with osteoporosis had a 66% relative risk reduction for invasive breast cancer"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "93"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 94  :List of 2
  ..$ content: chr "AIM: To describe surgical outcomes in patients with HER2-positive locally advanced (LABC) or inflammatory breas"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "94"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 95  :List of 2
  ..$ content: chr "High insulin-like growth factor-I (IGF-I) levels are associated with an increased risk of breast cancer in prem"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "95"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 96  :List of 2
  ..$ content: chr "In cooperative studies performed in 21 German clinics, the new cytostatic agent 3-(2-chloroethyl)-2-[(2-chloroe"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "96"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 97  :List of 2
  ..$ content: chr "BACKGROUND: Inadequate surgical excision with residual involvement of resection margins by tumour after breast "| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "97"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 98  :List of 2
  ..$ content: chr "PURPOSE: We examined in a prospective, randomized, international clinical trial the performance of a previously"| __truncated__
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "98"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
 $ 99  :List of 2
  ..$ content: chr ""
  ..$ meta   :List of 7
  .. ..$ author       : chr(0) 
  .. ..$ datetimestamp: POSIXlt[1:1], format: "2020-04-07 13:44:19"
  .. ..$ description  : chr(0) 
  .. ..$ heading      : chr(0) 
  .. ..$ id           : chr "99"
  .. ..$ language     : chr "en"
  .. ..$ origin       : chr(0) 
  .. ..- attr(*, "class")= chr "TextDocumentMeta"
  ..- attr(*, "class")= chr [1:2] "PlainTextDocument" "TextDocument"
  [list output truncated]
 - attr(*, "class")= chr [1:2] "VCorpus" "Corpus"
> corpusAbstract = VCorpus(VectorSource(trials$abstract))
> 
> corpusAbstract = tm_map(corpusAbstract, content_transformer(tolower))
> 
> corpusAbstract = tm_map(corpusAbstract, removePunctuation)
> 
> corpusAbstract = tm_map(corpusAbstract, removeWords, stopwords("english"))
> 
> corpusAbstract = tm_map(corpusAbstract, stemDocument)
> 
> dtmAbstract = DocumentTermMatrix(corpusAbstract)
> 
> dtmAbstract = removeSparseTerms(dtmAbstract, 0.95)
> 
> dtmAbstract = as.data.frame(as.matrix(dtmAbstract))
> str(dtmAbstract)
'data.frame':   1860 obs. of  335 variables:
 $ 0001           : num  0 0 0 0 0 7 0 0 0 0 ...
 $ 001            : num  0 0 0 1 0 0 0 1 0 0 ...
 $ 005            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ 100            : num  0 1 0 0 0 0 0 0 0 0 ...
 $ 500            : num  0 0 1 0 2 0 0 0 0 0 ...
 $ 5fluorouracil  : num  0 0 0 0 0 1 0 0 0 0 ...
 $ accord         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ achiev         : num  0 0 0 0 0 0 1 0 1 0 ...
 $ activ          : num  0 2 0 1 0 0 1 0 0 0 ...
 $ addit          : num  0 0 2 0 0 0 0 0 0 0 ...
 $ adjuv          : num  0 0 0 2 0 1 0 2 4 0 ...
 $ administ       : num  0 0 0 0 0 0 1 0 0 0 ...
 $ administr      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ advanc         : num  0 0 0 0 0 0 1 0 0 0 ...
 $ advers         : num  0 0 0 0 0 0 0 0 0 4 ...
 $ age            : num  0 0 0 1 0 0 0 0 0 0 ...
 $ agent          : num  0 0 0 0 1 0 1 0 0 0 ...
 $ aim            : num  0 0 0 0 0 1 0 0 0 0 ...
 $ alon           : num  0 0 0 0 0 0 0 0 3 0 ...
 $ also           : num  0 0 0 1 0 0 0 0 2 0 ...
 $ although       : num  0 0 0 0 0 0 0 0 0 0 ...
 $ among          : num  0 0 2 4 0 0 0 0 1 0 ...
 $ analys         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ analysi        : num  0 0 0 2 0 0 0 1 0 0 ...
 $ analyz         : num  0 0 0 1 0 0 0 0 0 0 ...
 $ andor          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ anthracyclin   : num  0 0 0 0 0 0 0 0 0 0 ...
 $ appear         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ arm            : num  0 0 7 4 2 0 0 1 0 1 ...
 $ aromatas       : num  0 0 0 0 0 0 0 1 0 0 ...
 $ assess         : num  0 2 1 2 0 1 0 0 0 3 ...
 $ assign         : num  0 0 2 1 0 0 0 1 1 1 ...
 $ associ         : num  0 0 1 3 0 2 0 1 2 0 ...
 $ avail          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ axillari       : num  0 0 0 1 0 0 0 0 1 0 ...
 $ background     : num  0 0 1 1 1 0 0 1 1 0 ...
 $ base           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ baselin        : num  0 0 0 0 0 0 0 0 0 1 ...
 $ benefit        : num  0 0 0 0 2 0 0 1 1 0 ...
 $ better         : num  0 0 1 0 1 1 0 0 0 0 ...
 $ bone           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ breast         : num  0 2 3 3 3 4 2 2 2 3 ...
 $ can            : num  0 0 0 0 0 0 0 0 1 0 ...
 $ cancer         : num  0 0 2 3 3 3 2 2 3 0 ...
 $ carcinoma      : num  0 5 0 0 0 0 0 0 0 2 ...
 $ case           : num  0 11 0 0 1 0 0 0 0 0 ...
 $ caus           : num  0 0 0 0 0 0 0 1 0 0 ...
 $ cell           : num  0 3 0 0 0 1 0 0 0 0 ...
 $ chang          : num  0 0 1 0 0 0 0 0 0 0 ...
 $ characterist   : num  0 0 0 0 0 0 0 0 0 0 ...
 $ chemotherapi   : num  0 0 1 2 3 5 2 0 1 0 ...
 $ clinic         : num  0 1 0 1 0 0 0 0 0 0 ...
 $ cmf            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ combin         : num  0 0 0 0 6 0 2 0 1 0 ...
 $ common         : num  0 0 0 0 0 0 0 0 0 3 ...
 $ compar         : num  0 0 1 2 0 0 0 1 1 1 ...
 $ comparison     : num  0 0 0 0 0 0 0 0 0 0 ...
 $ complet        : num  0 0 3 0 1 1 1 2 0 0 ...
 $ conclus        : num  0 0 1 0 1 0 0 0 0 0 ...
 $ conduct        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ confid         : num  0 0 1 1 0 0 0 0 0 0 ...
 $ confirm        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ consid         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ consist        : num  0 1 0 0 0 0 0 0 0 0 ...
 $ continu        : num  0 0 2 0 1 0 0 2 0 0 ...
 $ control        : num  0 1 0 0 0 0 0 0 1 0 ...
 $ correl         : num  0 0 0 0 0 2 0 0 0 0 ...
 $ cours          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ cycl           : num  0 0 6 0 2 0 1 0 0 0 ...
 $ cyclophosphamid: num  0 0 1 1 1 1 3 0 0 0 ...
 $ daili          : num  0 0 0 0 0 0 1 0 1 2 ...
 $ data           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ day            : num  0 0 1 0 0 0 3 0 0 0 ...
 $ death          : num  0 0 0 2 0 0 0 0 1 0 ...
 $ decreas        : num  0 0 1 0 0 0 0 0 1 0 ...
 $ defin          : num  0 0 2 0 0 0 0 0 0 0 ...
 $ demonstr       : num  0 0 1 0 0 0 0 0 0 0 ...
 $ design         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ detect         : num  0 0 0 0 1 0 0 0 0 0 ...
 $ determin       : num  0 0 0 0 1 1 1 0 0 0 ...
 $ develop        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ dfs            : num  0 0 0 3 0 0 0 0 0 0 ...
 $ differ         : num  0 1 2 1 3 0 0 1 0 1 ...
 $ diseas         : num  0 1 0 1 3 0 0 1 0 0 ...
 $ diseasefre     : num  0 0 0 1 0 2 0 0 3 0 ...
 $ distant        : num  0 0 0 0 0 0 0 0 1 0 ...
 $ docetaxel      : num  0 0 1 0 0 0 3 0 0 0 ...
 $ dose           : num  0 0 0 0 0 0 4 0 0 0 ...
 $ doubleblind    : num  0 0 0 0 0 0 0 0 0 1 ...
 $ doxorubicin    : num  0 0 1 0 0 1 0 0 0 0 ...
 $ drug           : num  0 0 0 1 0 0 0 0 0 0 ...
 $ due            : num  0 0 0 0 0 0 0 1 0 0 ...
 $ durat          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ earli          : num  0 0 0 0 0 0 0 2 0 0 ...
 $ effect         : num  0 0 2 0 0 1 0 2 0 1 ...
 $ efficaci       : num  0 0 1 0 0 0 0 0 0 0 ...
 $ eight          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ either         : num  0 0 0 0 1 0 0 0 0 0 ...
 $ elig           : num  0 0 0 1 0 0 0 0 0 0 ...
  [list output truncated]
> colnames(dtmTitle) = paste0("T", colnames(dtmTitle))
> colnames(dtmAbstract) = paste0("A", colnames(dtmAbstract))
> dtm = cbind(dtmTitle, dtmAbstract)
> str(dtm)
'data.frame':   1860 obs. of  366 variables:
 $ Tadjuv          : num  0 0 0 0 0 0 0 0 1 0 ...
 $ Tadvanc         : num  0 0 0 0 0 0 1 0 0 0 ...
 $ Tbreast         : num  0 0 1 1 1 1 0 1 1 1 ...
 $ Tcancer         : num  1 0 1 1 1 1 0 1 1 2 ...
 $ Tchemotherapi   : num  0 0 0 0 1 1 0 0 0 0 ...
 $ Tclinic         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tcombin         : num  0 0 0 0 1 0 1 0 0 0 ...
 $ Tcompar         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tcyclophosphamid: num  0 0 0 1 0 0 0 0 0 0 ...
 $ Tdocetaxel      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tdoxorubicin    : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tearli          : num  0 0 1 1 0 0 0 1 0 0 ...
 $ Teffect         : num  0 0 0 0 1 0 0 1 0 1 ...
 $ Tgroup          : num  0 0 0 0 0 0 0 0 1 1 ...
 $ Tiii            : num  0 0 1 0 0 0 0 0 0 1 ...
 $ Tmetastat       : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Tpatient        : num  0 0 0 0 1 0 1 0 1 1 ...
 $ Tphase          : num  0 0 1 1 0 0 0 0 0 1 ...
 $ Tplus           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tpostmenopaus   : num  0 0 0 0 0 0 0 1 1 0 ...
 $ Trandom         : num  0 0 1 1 1 0 0 0 0 1 ...
 $ Trandomis       : num  0 0 0 0 0 0 0 1 1 0 ...
 $ Trespons        : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Tresult         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tstudi          : num  0 0 0 0 0 0 0 1 0 0 ...
 $ Ttamoxifen      : num  0 0 0 0 0 0 0 2 1 0 ...
 $ Ttherapi        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Ttreatment      : num  1 0 0 0 1 0 0 0 0 1 ...
 $ Ttrial          : num  0 0 1 1 1 0 0 1 1 1 ...
 $ Tversus         : num  0 0 1 0 0 0 0 1 0 0 ...
 $ Twomen          : num  0 0 0 0 0 0 0 1 0 0 ...
 $ A0001           : num  0 0 0 0 0 7 0 0 0 0 ...
 $ A001            : num  0 0 0 1 0 0 0 1 0 0 ...
 $ A005            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ A100            : num  0 1 0 0 0 0 0 0 0 0 ...
 $ A500            : num  0 0 1 0 2 0 0 0 0 0 ...
 $ A5fluorouracil  : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Aaccord         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aachiev         : num  0 0 0 0 0 0 1 0 1 0 ...
 $ Aactiv          : num  0 2 0 1 0 0 1 0 0 0 ...
 $ Aaddit          : num  0 0 2 0 0 0 0 0 0 0 ...
 $ Aadjuv          : num  0 0 0 2 0 1 0 2 4 0 ...
 $ Aadminist       : num  0 0 0 0 0 0 1 0 0 0 ...
 $ Aadministr      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aadvanc         : num  0 0 0 0 0 0 1 0 0 0 ...
 $ Aadvers         : num  0 0 0 0 0 0 0 0 0 4 ...
 $ Aage            : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Aagent          : num  0 0 0 0 1 0 1 0 0 0 ...
 $ Aaim            : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Aalon           : num  0 0 0 0 0 0 0 0 3 0 ...
 $ Aalso           : num  0 0 0 1 0 0 0 0 2 0 ...
 $ Aalthough       : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aamong          : num  0 0 2 4 0 0 0 0 1 0 ...
 $ Aanalys         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanalysi        : num  0 0 0 2 0 0 0 1 0 0 ...
 $ Aanalyz         : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Aandor          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanthracyclin   : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aappear         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aarm            : num  0 0 7 4 2 0 0 1 0 1 ...
 $ Aaromatas       : num  0 0 0 0 0 0 0 1 0 0 ...
 $ Aassess         : num  0 2 1 2 0 1 0 0 0 3 ...
 $ Aassign         : num  0 0 2 1 0 0 0 1 1 1 ...
 $ Aassoci         : num  0 0 1 3 0 2 0 1 2 0 ...
 $ Aavail          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aaxillari       : num  0 0 0 1 0 0 0 0 1 0 ...
 $ Abackground     : num  0 0 1 1 1 0 0 1 1 0 ...
 $ Abase           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Abaselin        : num  0 0 0 0 0 0 0 0 0 1 ...
 $ Abenefit        : num  0 0 0 0 2 0 0 1 1 0 ...
 $ Abetter         : num  0 0 1 0 1 1 0 0 0 0 ...
 $ Abone           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Abreast         : num  0 2 3 3 3 4 2 2 2 3 ...
 $ Acan            : num  0 0 0 0 0 0 0 0 1 0 ...
 $ Acancer         : num  0 0 2 3 3 3 2 2 3 0 ...
 $ Acarcinoma      : num  0 5 0 0 0 0 0 0 0 2 ...
 $ Acase           : num  0 11 0 0 1 0 0 0 0 0 ...
 $ Acaus           : num  0 0 0 0 0 0 0 1 0 0 ...
 $ Acell           : num  0 3 0 0 0 1 0 0 0 0 ...
 $ Achang          : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Acharacterist   : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Achemotherapi   : num  0 0 1 2 3 5 2 0 1 0 ...
 $ Aclinic         : num  0 1 0 1 0 0 0 0 0 0 ...
 $ Acmf            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acombin         : num  0 0 0 0 6 0 2 0 1 0 ...
 $ Acommon         : num  0 0 0 0 0 0 0 0 0 3 ...
 $ Acompar         : num  0 0 1 2 0 0 0 1 1 1 ...
 $ Acomparison     : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acomplet        : num  0 0 3 0 1 1 1 2 0 0 ...
 $ Aconclus        : num  0 0 1 0 1 0 0 0 0 0 ...
 $ Aconduct        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconfid         : num  0 0 1 1 0 0 0 0 0 0 ...
 $ Aconfirm        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsid         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsist        : num  0 1 0 0 0 0 0 0 0 0 ...
 $ Acontinu        : num  0 0 2 0 1 0 0 2 0 0 ...
 $ Acontrol        : num  0 1 0 0 0 0 0 0 1 0 ...
 $ Acorrel         : num  0 0 0 0 0 2 0 0 0 0 ...
 $ Acours          : num  0 0 0 0 0 0 0 0 0 0 ...
  [list output truncated]
> dtm$trial = trials$trial
> split = sample.split(dtm$trial, SplitRatio=0,7)
Error in sample.split(dtm$trial, SplitRatio = 0, 7) : 
  Error in sample.split: Vectors 'Y' and 'group' have to have the same length
> split = sample.split(dtm$trial, SplitRatio=0.7)
> train = subset(dtm, split==TRUE)
> test = subset(dtm, split==FALSE)
> table(dtm$trials)
< table of extent 0 >
> str(dtm)
'data.frame':   1860 obs. of  367 variables:
 $ Tadjuv          : num  0 0 0 0 0 0 0 0 1 0 ...
 $ Tadvanc         : num  0 0 0 0 0 0 1 0 0 0 ...
 $ Tbreast         : num  0 0 1 1 1 1 0 1 1 1 ...
 $ Tcancer         : num  1 0 1 1 1 1 0 1 1 2 ...
 $ Tchemotherapi   : num  0 0 0 0 1 1 0 0 0 0 ...
 $ Tclinic         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tcombin         : num  0 0 0 0 1 0 1 0 0 0 ...
 $ Tcompar         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tcyclophosphamid: num  0 0 0 1 0 0 0 0 0 0 ...
 $ Tdocetaxel      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tdoxorubicin    : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tearli          : num  0 0 1 1 0 0 0 1 0 0 ...
 $ Teffect         : num  0 0 0 0 1 0 0 1 0 1 ...
 $ Tgroup          : num  0 0 0 0 0 0 0 0 1 1 ...
 $ Tiii            : num  0 0 1 0 0 0 0 0 0 1 ...
 $ Tmetastat       : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Tpatient        : num  0 0 0 0 1 0 1 0 1 1 ...
 $ Tphase          : num  0 0 1 1 0 0 0 0 0 1 ...
 $ Tplus           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tpostmenopaus   : num  0 0 0 0 0 0 0 1 1 0 ...
 $ Trandom         : num  0 0 1 1 1 0 0 0 0 1 ...
 $ Trandomis       : num  0 0 0 0 0 0 0 1 1 0 ...
 $ Trespons        : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Tresult         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tstudi          : num  0 0 0 0 0 0 0 1 0 0 ...
 $ Ttamoxifen      : num  0 0 0 0 0 0 0 2 1 0 ...
 $ Ttherapi        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Ttreatment      : num  1 0 0 0 1 0 0 0 0 1 ...
 $ Ttrial          : num  0 0 1 1 1 0 0 1 1 1 ...
 $ Tversus         : num  0 0 1 0 0 0 0 1 0 0 ...
 $ Twomen          : num  0 0 0 0 0 0 0 1 0 0 ...
 $ A0001           : num  0 0 0 0 0 7 0 0 0 0 ...
 $ A001            : num  0 0 0 1 0 0 0 1 0 0 ...
 $ A005            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ A100            : num  0 1 0 0 0 0 0 0 0 0 ...
 $ A500            : num  0 0 1 0 2 0 0 0 0 0 ...
 $ A5fluorouracil  : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Aaccord         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aachiev         : num  0 0 0 0 0 0 1 0 1 0 ...
 $ Aactiv          : num  0 2 0 1 0 0 1 0 0 0 ...
 $ Aaddit          : num  0 0 2 0 0 0 0 0 0 0 ...
 $ Aadjuv          : num  0 0 0 2 0 1 0 2 4 0 ...
 $ Aadminist       : num  0 0 0 0 0 0 1 0 0 0 ...
 $ Aadministr      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aadvanc         : num  0 0 0 0 0 0 1 0 0 0 ...
 $ Aadvers         : num  0 0 0 0 0 0 0 0 0 4 ...
 $ Aage            : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Aagent          : num  0 0 0 0 1 0 1 0 0 0 ...
 $ Aaim            : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Aalon           : num  0 0 0 0 0 0 0 0 3 0 ...
 $ Aalso           : num  0 0 0 1 0 0 0 0 2 0 ...
 $ Aalthough       : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aamong          : num  0 0 2 4 0 0 0 0 1 0 ...
 $ Aanalys         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanalysi        : num  0 0 0 2 0 0 0 1 0 0 ...
 $ Aanalyz         : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Aandor          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanthracyclin   : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aappear         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aarm            : num  0 0 7 4 2 0 0 1 0 1 ...
 $ Aaromatas       : num  0 0 0 0 0 0 0 1 0 0 ...
 $ Aassess         : num  0 2 1 2 0 1 0 0 0 3 ...
 $ Aassign         : num  0 0 2 1 0 0 0 1 1 1 ...
 $ Aassoci         : num  0 0 1 3 0 2 0 1 2 0 ...
 $ Aavail          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aaxillari       : num  0 0 0 1 0 0 0 0 1 0 ...
 $ Abackground     : num  0 0 1 1 1 0 0 1 1 0 ...
 $ Abase           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Abaselin        : num  0 0 0 0 0 0 0 0 0 1 ...
 $ Abenefit        : num  0 0 0 0 2 0 0 1 1 0 ...
 $ Abetter         : num  0 0 1 0 1 1 0 0 0 0 ...
 $ Abone           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Abreast         : num  0 2 3 3 3 4 2 2 2 3 ...
 $ Acan            : num  0 0 0 0 0 0 0 0 1 0 ...
 $ Acancer         : num  0 0 2 3 3 3 2 2 3 0 ...
 $ Acarcinoma      : num  0 5 0 0 0 0 0 0 0 2 ...
 $ Acase           : num  0 11 0 0 1 0 0 0 0 0 ...
 $ Acaus           : num  0 0 0 0 0 0 0 1 0 0 ...
 $ Acell           : num  0 3 0 0 0 1 0 0 0 0 ...
 $ Achang          : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Acharacterist   : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Achemotherapi   : num  0 0 1 2 3 5 2 0 1 0 ...
 $ Aclinic         : num  0 1 0 1 0 0 0 0 0 0 ...
 $ Acmf            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acombin         : num  0 0 0 0 6 0 2 0 1 0 ...
 $ Acommon         : num  0 0 0 0 0 0 0 0 0 3 ...
 $ Acompar         : num  0 0 1 2 0 0 0 1 1 1 ...
 $ Acomparison     : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acomplet        : num  0 0 3 0 1 1 1 2 0 0 ...
 $ Aconclus        : num  0 0 1 0 1 0 0 0 0 0 ...
 $ Aconduct        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconfid         : num  0 0 1 1 0 0 0 0 0 0 ...
 $ Aconfirm        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsid         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsist        : num  0 1 0 0 0 0 0 0 0 0 ...
 $ Acontinu        : num  0 0 2 0 1 0 0 2 0 0 ...
 $ Acontrol        : num  0 1 0 0 0 0 0 0 1 0 ...
 $ Acorrel         : num  0 0 0 0 0 2 0 0 0 0 ...
 $ Acours          : num  0 0 0 0 0 0 0 0 0 0 ...
  [list output truncated]
> table(dtm$Ttrials)
< table of extent 0 >
> dtm$trial[1]
[1] 1
> max(dtm$trial[1])
[1] 1
> split[1]
[1] FALSE
> train = subset(dtm, split==TRUE)
> str(train)
'data.frame':   1302 obs. of  367 variables:
 $ Tadjuv          : num  0 0 0 0 0 0 1 0 0 1 ...
 $ Tadvanc         : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Tbreast         : num  1 1 1 0 1 1 0 1 0 1 ...
 $ Tcancer         : num  1 1 1 0 1 2 1 1 1 1 ...
 $ Tchemotherapi   : num  0 0 1 0 0 0 0 1 0 0 ...
 $ Tclinic         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tcombin         : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Tcompar         : num  0 0 0 0 0 0 0 1 0 0 ...
 $ Tcyclophosphamid: num  0 1 0 0 0 0 0 0 0 1 ...
 $ Tdocetaxel      : num  0 0 0 0 0 0 0 0 0 1 ...
 $ Tdoxorubicin    : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tearli          : num  1 1 0 0 1 0 0 0 0 1 ...
 $ Teffect         : num  0 0 0 0 1 1 0 0 0 0 ...
 $ Tgroup          : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Tiii            : num  1 0 0 0 0 1 0 0 0 0 ...
 $ Tmetastat       : num  0 0 0 0 0 0 0 1 0 0 ...
 $ Tpatient        : num  0 0 0 1 0 1 0 0 0 0 ...
 $ Tphase          : num  1 1 0 0 0 1 0 0 0 0 ...
 $ Tplus           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tpostmenopaus   : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Trandom         : num  1 1 0 0 0 1 0 0 0 1 ...
 $ Trandomis       : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Trespons        : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Tresult         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tstudi          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Ttamoxifen      : num  0 0 0 0 2 0 0 0 0 0 ...
 $ Ttherapi        : num  0 0 0 0 0 0 1 0 0 0 ...
 $ Ttreatment      : num  0 0 0 0 0 1 0 0 1 0 ...
 $ Ttrial          : num  1 1 0 0 1 1 0 0 0 1 ...
 $ Tversus         : num  1 0 0 0 1 0 0 0 0 0 ...
 $ Twomen          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ A0001           : num  0 0 7 0 0 0 0 0 0 0 ...
 $ A001            : num  0 1 0 0 1 0 0 0 0 0 ...
 $ A005            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ A100            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ A500            : num  1 0 0 0 0 0 0 0 0 0 ...
 $ A5fluorouracil  : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Aaccord         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aachiev         : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Aactiv          : num  0 1 0 1 0 0 1 0 0 1 ...
 $ Aaddit          : num  2 0 0 0 0 0 1 0 0 0 ...
 $ Aadjuv          : num  0 2 1 0 2 0 0 0 0 1 ...
 $ Aadminist       : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Aadministr      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aadvanc         : num  0 0 0 1 0 0 0 0 2 0 ...
 $ Aadvers         : num  0 0 0 0 0 4 0 0 0 0 ...
 $ Aage            : num  0 1 0 0 0 0 0 1 0 0 ...
 $ Aagent          : num  0 0 0 1 0 0 1 0 2 1 ...
 $ Aaim            : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Aalon           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aalso           : num  0 1 0 0 0 0 0 0 0 0 ...
 $ Aalthough       : num  0 0 0 0 0 0 0 0 1 0 ...
 $ Aamong          : num  2 4 0 0 0 0 0 0 0 0 ...
 $ Aanalys         : num  0 0 0 0 0 0 0 0 0 1 ...
 $ Aanalysi        : num  0 2 0 0 1 0 0 0 0 0 ...
 $ Aanalyz         : num  0 1 0 0 0 0 0 0 0 0 ...
 $ Aandor          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanthracyclin   : num  0 0 0 0 0 0 0 0 0 1 ...
 $ Aappear         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aarm            : num  7 4 0 0 1 1 0 0 0 0 ...
 $ Aaromatas       : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Aassess         : num  1 2 1 0 0 3 0 0 0 0 ...
 $ Aassign         : num  2 1 0 0 1 1 0 0 0 3 ...
 $ Aassoci         : num  1 3 2 0 1 0 0 0 0 0 ...
 $ Aavail          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aaxillari       : num  0 1 0 0 0 0 0 0 0 2 ...
 $ Abackground     : num  1 1 0 0 1 0 0 0 0 0 ...
 $ Abase           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Abaselin        : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Abenefit        : num  0 0 0 0 1 0 0 0 3 0 ...
 $ Abetter         : num  1 0 1 0 0 0 0 2 0 0 ...
 $ Abone           : num  0 0 0 0 0 0 0 1 0 0 ...
 $ Abreast         : num  3 3 4 2 2 3 1 2 0 4 ...
 $ Acan            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acancer         : num  2 3 3 2 2 0 2 2 1 3 ...
 $ Acarcinoma      : num  0 0 0 0 0 2 0 0 1 0 ...
 $ Acase           : num  0 0 0 0 0 0 2 0 0 0 ...
 $ Acaus           : num  0 0 0 0 1 0 0 0 1 0 ...
 $ Acell           : num  0 0 1 0 0 0 0 1 0 0 ...
 $ Achang          : num  1 0 0 0 0 0 0 0 0 0 ...
 $ Acharacterist   : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Achemotherapi   : num  1 2 5 2 0 0 1 2 0 0 ...
 $ Aclinic         : num  0 1 0 0 0 0 0 0 0 0 ...
 $ Acmf            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acombin         : num  0 0 0 2 0 0 0 0 0 0 ...
 $ Acommon         : num  0 0 0 0 0 3 0 0 1 0 ...
 $ Acompar         : num  1 2 0 0 1 1 0 0 0 2 ...
 $ Acomparison     : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acomplet        : num  3 0 1 1 2 0 0 0 0 0 ...
 $ Aconclus        : num  1 0 0 0 0 0 0 0 0 1 ...
 $ Aconduct        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconfid         : num  1 1 0 0 0 0 0 0 0 0 ...
 $ Aconfirm        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsid         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsist        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acontinu        : num  2 0 0 0 2 0 0 2 0 0 ...
 $ Acontrol        : num  0 0 0 0 0 0 2 0 0 0 ...
 $ Acorrel         : num  0 0 2 0 0 0 0 0 0 0 ...
 $ Acours          : num  0 0 0 0 0 0 0 0 0 0 ...
  [list output truncated]
> test = subset(dtm, split==FALSE)
> str(test)
'data.frame':   558 obs. of  367 variables:
 $ Tadjuv          : num  0 0 0 1 0 0 1 0 1 0 ...
 $ Tadvanc         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tbreast         : num  0 0 1 1 1 1 1 1 1 0 ...
 $ Tcancer         : num  1 0 1 1 1 0 1 1 1 0 ...
 $ Tchemotherapi   : num  0 0 1 0 0 1 1 1 0 0 ...
 $ Tclinic         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tcombin         : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Tcompar         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tcyclophosphamid: num  0 0 0 0 2 0 0 0 0 0 ...
 $ Tdocetaxel      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tdoxorubicin    : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Tearli          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Teffect         : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Tgroup          : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Tiii            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tmetastat       : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Tpatient        : num  0 0 1 1 0 0 0 1 0 0 ...
 $ Tphase          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Tplus           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tpostmenopaus   : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Trandom         : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Trandomis       : num  0 0 0 1 1 0 0 1 1 0 ...
 $ Trespons        : num  0 0 0 0 0 1 0 1 1 0 ...
 $ Tresult         : num  0 0 0 0 0 0 1 1 0 0 ...
 $ Tstudi          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Ttamoxifen      : num  0 0 0 1 0 0 0 0 1 1 ...
 $ Ttherapi        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Ttreatment      : num  1 0 1 0 0 0 0 0 0 0 ...
 $ Ttrial          : num  0 0 1 1 0 0 0 1 1 0 ...
 $ Tversus         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Twomen          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ A0001           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ A001            : num  0 0 0 0 0 1 0 0 0 0 ...
 $ A005            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ A100            : num  0 1 0 0 0 0 0 0 0 0 ...
 $ A500            : num  0 0 2 0 0 0 0 0 1 0 ...
 $ A5fluorouracil  : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aaccord         : num  0 0 0 0 0 1 0 0 1 0 ...
 $ Aachiev         : num  0 0 0 1 0 1 0 0 0 0 ...
 $ Aactiv          : num  0 2 0 0 0 0 0 2 0 0 ...
 $ Aaddit          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aadjuv          : num  0 0 0 4 1 0 0 0 0 0 ...
 $ Aadminist       : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Aadministr      : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Aadvanc         : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Aadvers         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aage            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aagent          : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Aaim            : num  0 0 0 0 0 1 0 0 1 0 ...
 $ Aalon           : num  0 0 0 3 0 0 0 0 0 0 ...
 $ Aalso           : num  0 0 0 2 0 0 0 1 0 0 ...
 $ Aalthough       : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aamong          : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Aanalys         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanalysi        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanalyz         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aandor          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanthracyclin   : num  0 0 0 0 0 2 0 0 0 0 ...
 $ Aappear         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aarm            : num  0 0 2 0 3 5 0 0 0 0 ...
 $ Aaromatas       : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aassess         : num  0 2 0 0 1 0 0 1 2 0 ...
 $ Aassign         : num  0 0 0 1 0 1 0 0 0 0 ...
 $ Aassoci         : num  0 0 0 2 0 0 0 0 0 0 ...
 $ Aavail          : num  0 0 0 0 0 0 0 0 1 0 ...
 $ Aaxillari       : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Abackground     : num  0 0 1 1 0 0 0 0 1 0 ...
 $ Abase           : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Abaselin        : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Abenefit        : num  0 0 2 1 0 0 0 0 0 0 ...
 $ Abetter         : num  0 0 1 0 0 0 0 1 0 0 ...
 $ Abone           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Abreast         : num  0 2 3 2 2 2 0 3 5 0 ...
 $ Acan            : num  0 0 0 1 0 1 0 1 1 0 ...
 $ Acancer         : num  0 0 3 3 3 0 0 3 5 0 ...
 $ Acarcinoma      : num  0 5 0 0 0 2 0 0 2 0 ...
 $ Acase           : num  0 11 1 0 0 0 0 0 0 0 ...
 $ Acaus           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acell           : num  0 3 0 0 0 0 0 1 0 0 ...
 $ Achang          : num  0 0 0 0 1 1 0 0 0 0 ...
 $ Acharacterist   : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Achemotherapi   : num  0 0 3 1 3 4 0 5 0 0 ...
 $ Aclinic         : num  0 1 0 0 0 0 0 3 2 0 ...
 $ Acmf            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acombin         : num  0 0 6 1 3 0 0 0 1 0 ...
 $ Acommon         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acompar         : num  0 0 0 1 2 0 0 2 0 0 ...
 $ Acomparison     : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acomplet        : num  0 0 1 0 0 2 0 3 0 0 ...
 $ Aconclus        : num  0 0 1 0 0 0 0 0 1 0 ...
 $ Aconduct        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconfid         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconfirm        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsid         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsist        : num  0 1 0 0 0 0 0 0 0 0 ...
 $ Acontinu        : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Acontrol        : num  0 1 0 1 0 0 0 1 1 0 ...
 $ Acorrel         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acours          : num  0 0 0 0 1 0 0 0 0 0 ...
  [list output truncated]
> test$trial[1]
[1] 1
> table(train$trial)

  0   1 
730 572 
> 730/(730+572)
[1] 0.5606759
> 0.5606759
[1] 0.5606759
> 0.5606759
[1] 0.5606759
> trialCART = rpart(trial ~ ., data=train, method="class")
> prp(trialCART)
> pred = predict(trailCART, newdata=train)
Error in predict(trailCART, newdata = train) : 
  object 'trailCART' not found
> pred = predict(trialCART, newdata=train)
> pred
             0          1
3    0.1313131 0.86868687
4    0.1313131 0.86868687
6    0.9423077 0.05769231
7    0.2530864 0.74691358
8    0.8832998 0.11670020
10   0.1313131 0.86868687
11   0.3157895 0.68421053
12   0.3142857 0.68571429
14   0.7301587 0.26984127
16   0.2530864 0.74691358
19   0.3142857 0.68571429
20   0.8832998 0.11670020
22   0.3142857 0.68571429
23   0.1313131 0.86868687
24   0.8832998 0.11670020
25   0.3157895 0.68421053
26   0.7586207 0.24137931
27   0.7586207 0.24137931
28   0.1313131 0.86868687
30   0.8832998 0.11670020
31   0.8832998 0.11670020
32   0.8832998 0.11670020
33   0.3142857 0.68571429
35   0.2530864 0.74691358
37   0.1313131 0.86868687
38   0.1313131 0.86868687
39   0.8832998 0.11670020
41   0.2530864 0.74691358
42   0.8832998 0.11670020
43   0.8832998 0.11670020
44   0.3142857 0.68571429
45   0.3157895 0.68421053
46   0.1313131 0.86868687
47   0.8832998 0.11670020
48   0.7586207 0.24137931
49   0.9423077 0.05769231
50   0.8832998 0.11670020
51   0.8832998 0.11670020
53   0.1313131 0.86868687
54   0.8832998 0.11670020
56   0.8832998 0.11670020
58   0.1313131 0.86868687
59   0.2530864 0.74691358
60   0.1313131 0.86868687
61   0.2530864 0.74691358
62   0.1313131 0.86868687
64   0.8832998 0.11670020
65   0.1313131 0.86868687
66   0.8832998 0.11670020
67   0.1313131 0.86868687
68   0.1313131 0.86868687
69   0.8832998 0.11670020
70   0.8832998 0.11670020
71   0.1313131 0.86868687
73   0.1313131 0.86868687
74   0.8832998 0.11670020
75   0.2530864 0.74691358
77   0.8832998 0.11670020
78   0.9423077 0.05769231
79   0.2530864 0.74691358
80   0.1313131 0.86868687
81   0.7301587 0.26984127
85   0.1313131 0.86868687
87   0.8832998 0.11670020
88   0.8832998 0.11670020
89   0.1313131 0.86868687
91   0.2530864 0.74691358
92   0.2530864 0.74691358
93   0.8832998 0.11670020
94   0.7301587 0.26984127
95   0.8832998 0.11670020
97   0.9090909 0.09090909
98   0.8832998 0.11670020
99   0.8832998 0.11670020
100  0.8832998 0.11670020
101  0.1313131 0.86868687
103  0.8832998 0.11670020
105  0.8832998 0.11670020
106  0.1313131 0.86868687
107  0.1313131 0.86868687
108  0.2530864 0.74691358
109  0.8832998 0.11670020
111  0.2530864 0.74691358
113  0.1313131 0.86868687
114  0.3157895 0.68421053
117  0.1313131 0.86868687
118  0.8832998 0.11670020
119  0.8832998 0.11670020
120  0.9423077 0.05769231
123  0.2530864 0.74691358
125  0.1313131 0.86868687
126  0.2530864 0.74691358
128  0.8832998 0.11670020
129  0.8832998 0.11670020
130  0.8832998 0.11670020
131  0.2530864 0.74691358
132  0.8832998 0.11670020
133  0.8832998 0.11670020
134  0.8832998 0.11670020
135  0.1313131 0.86868687
137  0.8832998 0.11670020
138  0.9423077 0.05769231
140  0.8832998 0.11670020
141  0.1313131 0.86868687
143  0.8832998 0.11670020
146  0.2530864 0.74691358
147  0.7586207 0.24137931
148  0.9423077 0.05769231
149  0.8832998 0.11670020
150  0.8832998 0.11670020
151  0.2530864 0.74691358
153  0.3157895 0.68421053
155  0.8832998 0.11670020
156  0.9090909 0.09090909
158  0.3142857 0.68571429
159  0.7301587 0.26984127
160  0.8832998 0.11670020
161  0.1313131 0.86868687
162  0.1313131 0.86868687
164  0.1313131 0.86868687
165  0.9423077 0.05769231
167  0.0952381 0.90476190
168  0.8832998 0.11670020
170  0.7586207 0.24137931
171  0.8181818 0.18181818
173  0.2530864 0.74691358
174  0.7727273 0.22727273
177  0.2530864 0.74691358
178  0.7301587 0.26984127
179  0.8832998 0.11670020
182  0.8832998 0.11670020
183  0.8832998 0.11670020
185  0.8832998 0.11670020
186  0.2530864 0.74691358
187  0.8832998 0.11670020
188  0.2530864 0.74691358
189  0.8832998 0.11670020
190  0.2530864 0.74691358
191  0.8832998 0.11670020
192  0.1313131 0.86868687
195  0.1313131 0.86868687
196  0.8832998 0.11670020
197  0.8832998 0.11670020
198  0.8832998 0.11670020
199  0.8832998 0.11670020
200  0.2530864 0.74691358
202  0.1313131 0.86868687
203  0.7586207 0.24137931
204  0.3157895 0.68421053
205  0.3142857 0.68571429
206  0.7301587 0.26984127
207  0.1313131 0.86868687
210  0.7586207 0.24137931
211  0.8832998 0.11670020
212  0.2530864 0.74691358
214  0.3157895 0.68421053
215  0.8832998 0.11670020
217  0.2530864 0.74691358
218  0.2530864 0.74691358
219  0.9423077 0.05769231
220  0.2530864 0.74691358
221  0.8832998 0.11670020
224  0.8832998 0.11670020
225  0.1313131 0.86868687
226  0.7586207 0.24137931
227  0.1313131 0.86868687
228  0.1313131 0.86868687
229  0.8832998 0.11670020
230  0.8832998 0.11670020
231  0.8832998 0.11670020
232  0.8832998 0.11670020
233  0.1313131 0.86868687
234  0.2530864 0.74691358
235  0.7301587 0.26984127
236  0.8832998 0.11670020
238  0.8832998 0.11670020
240  0.2530864 0.74691358
241  0.9423077 0.05769231
243  0.8832998 0.11670020
246  0.8832998 0.11670020
248  0.8832998 0.11670020
249  0.2530864 0.74691358
250  0.8832998 0.11670020
251  0.2530864 0.74691358
253  0.7301587 0.26984127
254  0.7727273 0.22727273
255  0.3142857 0.68571429
257  0.2530864 0.74691358
258  0.8832998 0.11670020
259  0.8832998 0.11670020
260  0.8832998 0.11670020
261  0.8832998 0.11670020
262  0.8832998 0.11670020
265  0.1313131 0.86868687
267  0.1313131 0.86868687
268  0.8832998 0.11670020
269  0.7301587 0.26984127
270  0.8832998 0.11670020
272  0.8832998 0.11670020
273  0.8832998 0.11670020
274  0.8832998 0.11670020
275  0.8832998 0.11670020
276  0.8832998 0.11670020
278  0.8832998 0.11670020
279  0.8832998 0.11670020
282  0.2530864 0.74691358
283  0.2530864 0.74691358
287  0.8832998 0.11670020
288  0.7586207 0.24137931
289  0.2530864 0.74691358
290  0.8832998 0.11670020
292  0.8832998 0.11670020
293  0.8832998 0.11670020
294  0.1313131 0.86868687
296  0.8832998 0.11670020
297  0.2530864 0.74691358
299  0.7586207 0.24137931
302  0.8832998 0.11670020
303  0.9423077 0.05769231
304  0.9423077 0.05769231
305  0.9423077 0.05769231
306  0.8832998 0.11670020
307  0.8832998 0.11670020
308  0.8832998 0.11670020
310  0.2530864 0.74691358
313  0.3157895 0.68421053
314  0.2530864 0.74691358
316  0.1313131 0.86868687
317  0.8832998 0.11670020
319  0.9423077 0.05769231
320  0.8832998 0.11670020
322  0.8832998 0.11670020
323  0.7586207 0.24137931
324  0.8832998 0.11670020
325  0.7727273 0.22727273
328  0.2530864 0.74691358
329  0.9423077 0.05769231
330  0.8832998 0.11670020
333  0.8832998 0.11670020
334  0.2530864 0.74691358
335  0.8832998 0.11670020
338  0.2530864 0.74691358
340  0.1313131 0.86868687
342  0.9090909 0.09090909
343  0.8832998 0.11670020
344  0.8832998 0.11670020
345  0.8832998 0.11670020
350  0.8832998 0.11670020
351  0.8832998 0.11670020
352  0.8832998 0.11670020
353  0.9423077 0.05769231
354  0.8832998 0.11670020
356  0.8832998 0.11670020
358  0.8832998 0.11670020
360  0.1313131 0.86868687
361  0.9423077 0.05769231
362  0.8832998 0.11670020
363  0.3142857 0.68571429
364  0.8832998 0.11670020
365  0.8832998 0.11670020
367  0.1313131 0.86868687
368  0.1313131 0.86868687
369  0.7301587 0.26984127
370  0.1313131 0.86868687
371  0.8832998 0.11670020
372  0.8832998 0.11670020
374  0.3142857 0.68571429
375  0.8832998 0.11670020
376  0.7727273 0.22727273
377  0.8832998 0.11670020
378  0.8832998 0.11670020
380  0.7586207 0.24137931
385  0.2530864 0.74691358
388  0.1313131 0.86868687
389  0.9423077 0.05769231
390  0.7586207 0.24137931
393  0.9423077 0.05769231
394  0.8832998 0.11670020
395  0.3142857 0.68571429
397  0.7727273 0.22727273
398  0.8832998 0.11670020
399  0.8832998 0.11670020
400  0.7301587 0.26984127
401  0.1313131 0.86868687
402  0.1313131 0.86868687
404  0.7586207 0.24137931
405  0.8181818 0.18181818
406  0.8832998 0.11670020
407  0.8832998 0.11670020
408  0.8832998 0.11670020
411  0.8832998 0.11670020
412  0.8832998 0.11670020
413  0.2530864 0.74691358
416  0.8832998 0.11670020
417  0.9423077 0.05769231
418  0.7586207 0.24137931
419  0.9423077 0.05769231
420  0.8832998 0.11670020
421  0.8832998 0.11670020
422  0.0952381 0.90476190
423  0.8832998 0.11670020
425  0.8832998 0.11670020
426  0.8832998 0.11670020
428  0.8832998 0.11670020
430  0.3142857 0.68571429
431  0.1313131 0.86868687
433  0.1313131 0.86868687
434  0.8832998 0.11670020
435  0.3142857 0.68571429
436  0.3142857 0.68571429
437  0.8832998 0.11670020
438  0.8832998 0.11670020
440  0.8832998 0.11670020
441  0.1313131 0.86868687
442  0.0952381 0.90476190
443  0.1313131 0.86868687
444  0.1313131 0.86868687
445  0.8832998 0.11670020
446  0.8832998 0.11670020
449  0.8832998 0.11670020
454  0.0952381 0.90476190
455  0.8832998 0.11670020
457  0.8832998 0.11670020
458  0.8832998 0.11670020
459  0.2530864 0.74691358
461  0.7301587 0.26984127
462  0.2530864 0.74691358
463  0.7301587 0.26984127
464  0.2530864 0.74691358
467  0.7301587 0.26984127
468  0.8832998 0.11670020
469  0.8832998 0.11670020
470  0.8832998 0.11670020
471  0.7586207 0.24137931
473  0.2530864 0.74691358
474  0.8832998 0.11670020
475  0.8832998 0.11670020
476  0.7301587 0.26984127
477  0.8832998 0.11670020
478  0.7586207 0.24137931
479  0.9090909 0.09090909
483  0.8832998 0.11670020
485  0.7586207 0.24137931
486  0.9423077 0.05769231
488  0.7586207 0.24137931
489  0.1313131 0.86868687
490  0.3157895 0.68421053
491  0.3142857 0.68571429
493  0.1313131 0.86868687
494  0.3142857 0.68571429
495  0.3157895 0.68421053
499  0.3142857 0.68571429
500  0.2530864 0.74691358
507  0.8832998 0.11670020
508  0.8832998 0.11670020
509  0.8832998 0.11670020
510  0.1313131 0.86868687
511  0.8832998 0.11670020
514  0.9423077 0.05769231
515  0.8832998 0.11670020
516  0.8832998 0.11670020
517  0.1313131 0.86868687
518  0.8832998 0.11670020
519  0.8832998 0.11670020
520  0.2530864 0.74691358
521  0.2530864 0.74691358
524  0.7301587 0.26984127
526  0.8832998 0.11670020
529  0.8832998 0.11670020
530  0.2530864 0.74691358
531  0.8832998 0.11670020
532  0.2530864 0.74691358
533  0.3142857 0.68571429
535  0.7727273 0.22727273
538  0.8832998 0.11670020
541  0.7586207 0.24137931
542  0.9423077 0.05769231
543  0.8832998 0.11670020
544  0.8832998 0.11670020
545  0.1313131 0.86868687
546  0.9090909 0.09090909
547  0.8832998 0.11670020
549  0.7301587 0.26984127
550  0.3142857 0.68571429
551  0.8832998 0.11670020
552  0.2530864 0.74691358
553  0.8832998 0.11670020
554  0.7586207 0.24137931
555  0.8832998 0.11670020
557  0.8832998 0.11670020
559  0.8832998 0.11670020
560  0.2530864 0.74691358
561  0.8832998 0.11670020
562  0.8832998 0.11670020
565  0.8832998 0.11670020
566  0.3142857 0.68571429
571  0.2530864 0.74691358
573  0.8832998 0.11670020
575  0.2530864 0.74691358
576  0.8832998 0.11670020
577  0.8832998 0.11670020
579  0.3142857 0.68571429
582  0.8832998 0.11670020
583  0.2530864 0.74691358
584  0.1313131 0.86868687
585  0.8832998 0.11670020
586  0.8832998 0.11670020
587  0.8832998 0.11670020
588  0.8832998 0.11670020
589  0.1313131 0.86868687
590  0.1313131 0.86868687
591  0.0952381 0.90476190
592  0.8832998 0.11670020
593  0.7727273 0.22727273
595  0.3142857 0.68571429
596  0.1313131 0.86868687
597  0.8832998 0.11670020
598  0.8832998 0.11670020
599  0.8832998 0.11670020
600  0.3142857 0.68571429
601  0.7301587 0.26984127
602  0.2530864 0.74691358
603  0.2530864 0.74691358
604  0.8832998 0.11670020
607  0.8832998 0.11670020
610  0.8832998 0.11670020
612  0.7727273 0.22727273
615  0.7301587 0.26984127
616  0.9423077 0.05769231
617  0.2530864 0.74691358
618  0.7586207 0.24137931
622  0.8832998 0.11670020
624  0.8832998 0.11670020
626  0.8832998 0.11670020
627  0.8832998 0.11670020
628  0.8832998 0.11670020
632  0.1313131 0.86868687
634  0.9423077 0.05769231
635  0.3142857 0.68571429
636  0.9423077 0.05769231
637  0.3142857 0.68571429
638  0.7586207 0.24137931
639  0.7301587 0.26984127
640  0.9423077 0.05769231
643  0.2530864 0.74691358
645  0.8181818 0.18181818
646  0.8832998 0.11670020
648  0.8832998 0.11670020
651  0.8832998 0.11670020
652  0.7586207 0.24137931
653  0.7586207 0.24137931
655  0.2530864 0.74691358
656  0.1313131 0.86868687
659  0.7586207 0.24137931
661  0.8832998 0.11670020
662  0.9423077 0.05769231
664  0.7586207 0.24137931
666  0.7586207 0.24137931
667  0.8832998 0.11670020
668  0.9423077 0.05769231
669  0.0952381 0.90476190
670  0.8832998 0.11670020
671  0.3142857 0.68571429
672  0.2530864 0.74691358
674  0.9423077 0.05769231
676  0.2530864 0.74691358
677  0.2530864 0.74691358
678  0.8832998 0.11670020
679  0.1313131 0.86868687
681  0.3142857 0.68571429
682  0.8832998 0.11670020
683  0.2530864 0.74691358
685  0.2530864 0.74691358
686  0.8832998 0.11670020
687  0.1313131 0.86868687
689  0.8832998 0.11670020
690  0.2530864 0.74691358
691  0.8832998 0.11670020
692  0.8832998 0.11670020
693  0.2530864 0.74691358
694  0.1313131 0.86868687
699  0.8832998 0.11670020
700  0.3142857 0.68571429
701  0.9423077 0.05769231
703  0.8832998 0.11670020
704  0.1313131 0.86868687
705  0.8832998 0.11670020
707  0.1313131 0.86868687
709  0.2530864 0.74691358
710  0.8832998 0.11670020
712  0.9423077 0.05769231
713  0.8832998 0.11670020
715  0.1313131 0.86868687
716  0.8832998 0.11670020
717  0.2530864 0.74691358
718  0.8832998 0.11670020
719  0.2530864 0.74691358
721  0.8832998 0.11670020
722  0.8832998 0.11670020
727  0.2530864 0.74691358
728  0.7586207 0.24137931
729  0.8832998 0.11670020
730  0.8832998 0.11670020
731  0.8832998 0.11670020
732  0.8832998 0.11670020
733  0.2530864 0.74691358
737  0.2530864 0.74691358
738  0.0952381 0.90476190
739  0.8832998 0.11670020
740  0.8832998 0.11670020
741  0.0952381 0.90476190
742  0.8832998 0.11670020
744  0.1313131 0.86868687
745  0.8832998 0.11670020
747  0.8832998 0.11670020
748  0.8832998 0.11670020
749  0.1313131 0.86868687
750  0.7586207 0.24137931
752  0.8832998 0.11670020
753  0.1313131 0.86868687
754  0.1313131 0.86868687
755  0.8832998 0.11670020
756  0.7301587 0.26984127
757  0.8181818 0.18181818
758  0.8832998 0.11670020
759  0.1313131 0.86868687
760  0.3157895 0.68421053
761  0.7727273 0.22727273
762  0.8832998 0.11670020
763  0.1313131 0.86868687
764  0.7727273 0.22727273
766  0.2530864 0.74691358
767  0.7586207 0.24137931
768  0.3157895 0.68421053
770  0.2530864 0.74691358
771  0.3142857 0.68571429
772  0.8832998 0.11670020
773  0.9423077 0.05769231
774  0.8832998 0.11670020
776  0.7586207 0.24137931
777  0.1313131 0.86868687
779  0.3142857 0.68571429
780  0.3142857 0.68571429
781  0.2530864 0.74691358
782  0.8832998 0.11670020
784  0.9423077 0.05769231
788  0.8832998 0.11670020
789  0.9423077 0.05769231
790  0.8832998 0.11670020
791  0.2530864 0.74691358
792  0.0952381 0.90476190
793  0.8832998 0.11670020
794  0.7586207 0.24137931
795  0.8832998 0.11670020
797  0.8832998 0.11670020
798  0.9423077 0.05769231
799  0.8832998 0.11670020
803  0.8832998 0.11670020
804  0.8832998 0.11670020
805  0.8832998 0.11670020
806  0.0952381 0.90476190
807  0.8832998 0.11670020
810  0.8832998 0.11670020
811  0.8832998 0.11670020
812  0.8832998 0.11670020
813  0.1313131 0.86868687
814  0.1313131 0.86868687
817  0.2530864 0.74691358
818  0.8832998 0.11670020
819  0.8832998 0.11670020
822  0.7586207 0.24137931
825  0.3142857 0.68571429
827  0.8832998 0.11670020
828  0.9423077 0.05769231
829  0.8832998 0.11670020
831  0.8832998 0.11670020
832  0.8832998 0.11670020
834  0.7586207 0.24137931
836  0.2530864 0.74691358
837  0.2530864 0.74691358
838  0.2530864 0.74691358
839  0.8832998 0.11670020
840  0.3142857 0.68571429
841  0.3157895 0.68421053
842  0.7301587 0.26984127
843  0.8832998 0.11670020
845  0.3157895 0.68421053
846  0.8832998 0.11670020
847  0.8832998 0.11670020
848  0.8832998 0.11670020
852  0.9423077 0.05769231
853  0.1313131 0.86868687
856  0.3142857 0.68571429
857  0.8832998 0.11670020
859  0.3142857 0.68571429
860  0.3157895 0.68421053
861  0.2530864 0.74691358
862  0.8832998 0.11670020
863  0.0952381 0.90476190
864  0.8832998 0.11670020
865  0.8832998 0.11670020
866  0.8832998 0.11670020
869  0.8832998 0.11670020
870  0.8832998 0.11670020
872  0.8832998 0.11670020
874  0.2530864 0.74691358
876  0.1313131 0.86868687
877  0.8832998 0.11670020
879  0.3142857 0.68571429
880  0.7727273 0.22727273
881  0.8832998 0.11670020
883  0.2530864 0.74691358
884  0.7301587 0.26984127
885  0.3142857 0.68571429
887  0.8832998 0.11670020
889  0.9423077 0.05769231
890  0.3142857 0.68571429
891  0.1313131 0.86868687
892  0.8832998 0.11670020
893  0.8832998 0.11670020
894  0.9423077 0.05769231
897  0.8832998 0.11670020
899  0.8832998 0.11670020
900  0.8832998 0.11670020
901  0.8832998 0.11670020
902  0.2530864 0.74691358
903  0.1313131 0.86868687
904  0.2530864 0.74691358
905  0.2530864 0.74691358
907  0.7301587 0.26984127
910  0.8832998 0.11670020
911  0.2530864 0.74691358
914  0.2530864 0.74691358
915  0.7586207 0.24137931
916  0.8832998 0.11670020
917  0.3142857 0.68571429
918  0.8832998 0.11670020
919  0.7301587 0.26984127
920  0.3142857 0.68571429
922  0.2530864 0.74691358
923  0.8832998 0.11670020
924  0.2530864 0.74691358
926  0.7586207 0.24137931
927  0.8832998 0.11670020
928  0.2530864 0.74691358
929  0.8832998 0.11670020
930  0.3157895 0.68421053
931  0.7586207 0.24137931
932  0.1313131 0.86868687
933  0.0952381 0.90476190
936  0.2530864 0.74691358
937  0.7586207 0.24137931
939  0.8832998 0.11670020
940  0.2530864 0.74691358
941  0.0952381 0.90476190
943  0.8832998 0.11670020
945  0.7301587 0.26984127
948  0.8832998 0.11670020
949  0.8832998 0.11670020
951  0.3142857 0.68571429
952  0.7301587 0.26984127
953  0.8832998 0.11670020
954  0.8832998 0.11670020
955  0.8832998 0.11670020
956  0.7301587 0.26984127
957  0.2530864 0.74691358
958  0.3142857 0.68571429
959  0.8832998 0.11670020
962  0.1313131 0.86868687
963  0.2530864 0.74691358
964  0.7301587 0.26984127
966  0.2530864 0.74691358
968  0.1313131 0.86868687
969  0.1313131 0.86868687
970  0.8832998 0.11670020
972  0.7586207 0.24137931
973  0.2530864 0.74691358
974  0.7301587 0.26984127
975  0.8832998 0.11670020
976  0.8832998 0.11670020
977  0.8832998 0.11670020
978  0.7586207 0.24137931
983  0.2530864 0.74691358
984  0.3142857 0.68571429
985  0.2530864 0.74691358
988  0.7301587 0.26984127
989  0.8832998 0.11670020
990  0.7586207 0.24137931
991  0.2530864 0.74691358
992  0.8832998 0.11670020
993  0.7727273 0.22727273
994  0.8832998 0.11670020
995  0.1313131 0.86868687
997  0.9090909 0.09090909
1001 0.2530864 0.74691358
1002 0.7586207 0.24137931
1003 0.3157895 0.68421053
1004 0.2530864 0.74691358
1005 0.8832998 0.11670020
1006 0.8832998 0.11670020
1008 0.3142857 0.68571429
1009 0.8832998 0.11670020
1011 0.7727273 0.22727273
1012 0.8832998 0.11670020
1014 0.8832998 0.11670020
1015 0.9423077 0.05769231
1016 0.7301587 0.26984127
1019 0.8832998 0.11670020
1020 0.8832998 0.11670020
1022 0.1313131 0.86868687
1023 0.8832998 0.11670020
1024 0.8832998 0.11670020
1026 0.8832998 0.11670020
1027 0.2530864 0.74691358
1029 0.8832998 0.11670020
1032 0.7301587 0.26984127
1033 0.8832998 0.11670020
1034 0.9423077 0.05769231
1036 0.8832998 0.11670020
1037 0.2530864 0.74691358
1038 0.7586207 0.24137931
1039 0.7301587 0.26984127
1042 0.2530864 0.74691358
1043 0.3142857 0.68571429
1045 0.9423077 0.05769231
1047 0.9423077 0.05769231
1048 0.7301587 0.26984127
1049 0.8832998 0.11670020
1050 0.8832998 0.11670020
1051 0.8832998 0.11670020
1052 0.8832998 0.11670020
1054 0.2530864 0.74691358
1055 0.1313131 0.86868687
1056 0.8832998 0.11670020
1057 0.8832998 0.11670020
1058 0.8832998 0.11670020
1059 0.1313131 0.86868687
1060 0.3142857 0.68571429
1061 0.8832998 0.11670020
1062 0.8832998 0.11670020
1063 0.8832998 0.11670020
1065 0.8832998 0.11670020
1066 0.3157895 0.68421053
1067 0.8832998 0.11670020
1069 0.8832998 0.11670020
1070 0.8832998 0.11670020
1071 0.8832998 0.11670020
1073 0.8832998 0.11670020
1074 0.7586207 0.24137931
1075 0.3157895 0.68421053
1076 0.8832998 0.11670020
1081 0.7586207 0.24137931
1085 0.2530864 0.74691358
1086 0.7586207 0.24137931
1088 0.2530864 0.74691358
1089 0.2530864 0.74691358
1090 0.7301587 0.26984127
1091 0.2530864 0.74691358
1092 0.8832998 0.11670020
1093 0.1313131 0.86868687
1094 0.8832998 0.11670020
1096 0.3142857 0.68571429
1097 0.0952381 0.90476190
1098 0.8832998 0.11670020
1099 0.8832998 0.11670020
1101 0.3142857 0.68571429
1104 0.8832998 0.11670020
1105 0.9423077 0.05769231
1106 0.3142857 0.68571429
1107 0.1313131 0.86868687
1108 0.9423077 0.05769231
1110 0.8832998 0.11670020
1111 0.3142857 0.68571429
1112 0.8832998 0.11670020
1114 0.1313131 0.86868687
1115 0.7301587 0.26984127
1117 0.1313131 0.86868687
1118 0.1313131 0.86868687
1119 0.2530864 0.74691358
1120 0.3142857 0.68571429
1122 0.3157895 0.68421053
1124 0.1313131 0.86868687
1125 0.1313131 0.86868687
1127 0.8832998 0.11670020
1128 0.3157895 0.68421053
1129 0.8832998 0.11670020
1130 0.7727273 0.22727273
1131 0.9090909 0.09090909
1132 0.2530864 0.74691358
1133 0.1313131 0.86868687
1134 0.9090909 0.09090909
1135 0.8832998 0.11670020
1137 0.8832998 0.11670020
1138 0.8832998 0.11670020
1139 0.2530864 0.74691358
1140 0.8832998 0.11670020
1141 0.7301587 0.26984127
1142 0.8832998 0.11670020
1143 0.8832998 0.11670020
1144 0.7586207 0.24137931
1145 0.8832998 0.11670020
1146 0.7301587 0.26984127
1147 0.7301587 0.26984127
1148 0.8832998 0.11670020
1149 0.2530864 0.74691358
1150 0.8832998 0.11670020
1151 0.1313131 0.86868687
1152 0.7586207 0.24137931
1154 0.2530864 0.74691358
1155 0.2530864 0.74691358
1156 0.8832998 0.11670020
1157 0.3142857 0.68571429
1158 0.8832998 0.11670020
1159 0.2530864 0.74691358
1160 0.9423077 0.05769231
1161 0.8832998 0.11670020
1162 0.8832998 0.11670020
1163 0.8832998 0.11670020
1165 0.2530864 0.74691358
1168 0.8181818 0.18181818
1170 0.8832998 0.11670020
1171 0.8832998 0.11670020
1172 0.8832998 0.11670020
1177 0.3142857 0.68571429
1178 0.1313131 0.86868687
1179 0.2530864 0.74691358
1180 0.8832998 0.11670020
1181 0.3157895 0.68421053
1182 0.8832998 0.11670020
1183 0.7301587 0.26984127
1184 0.8832998 0.11670020
1185 0.7301587 0.26984127
1189 0.8832998 0.11670020
1194 0.2530864 0.74691358
1197 0.8832998 0.11670020
1198 0.9423077 0.05769231
1202 0.8832998 0.11670020
1203 0.3142857 0.68571429
1204 0.8832998 0.11670020
1205 0.8181818 0.18181818
1208 0.8832998 0.11670020
1209 0.8832998 0.11670020
1210 0.3157895 0.68421053
1211 0.8832998 0.11670020
1213 0.7301587 0.26984127
1214 0.8832998 0.11670020
1217 0.7586207 0.24137931
1218 0.8832998 0.11670020
1220 0.0952381 0.90476190
1221 0.7301587 0.26984127
1222 0.2530864 0.74691358
1223 0.3157895 0.68421053
1225 0.7586207 0.24137931
1226 0.0952381 0.90476190
1228 0.2530864 0.74691358
1229 0.8832998 0.11670020
1232 0.8832998 0.11670020
1233 0.2530864 0.74691358
1234 0.1313131 0.86868687
1235 0.8832998 0.11670020
1236 0.2530864 0.74691358
1237 0.8832998 0.11670020
1240 0.1313131 0.86868687
1241 0.9423077 0.05769231
1242 0.8181818 0.18181818
1243 0.8832998 0.11670020
1244 0.8832998 0.11670020
1246 0.2530864 0.74691358
1247 0.7301587 0.26984127
1248 0.8832998 0.11670020
1250 0.7727273 0.22727273
1251 0.0952381 0.90476190
1254 0.8832998 0.11670020
1255 0.8832998 0.11670020
1256 0.2530864 0.74691358
1257 0.3142857 0.68571429
1259 0.8832998 0.11670020
1260 0.1313131 0.86868687
1261 0.8832998 0.11670020
1262 0.7301587 0.26984127
1263 0.3157895 0.68421053
1264 0.8832998 0.11670020
1265 0.7301587 0.26984127
1266 0.9423077 0.05769231
1267 0.8832998 0.11670020
1268 0.8832998 0.11670020
1269 0.9090909 0.09090909
1270 0.2530864 0.74691358
1272 0.8832998 0.11670020
1273 0.8832998 0.11670020
1274 0.8832998 0.11670020
1275 0.8832998 0.11670020
1276 0.1313131 0.86868687
1277 0.8832998 0.11670020
1278 0.1313131 0.86868687
1279 0.7586207 0.24137931
1280 0.1313131 0.86868687
1281 0.0952381 0.90476190
1283 0.7727273 0.22727273
1284 0.3142857 0.68571429
1285 0.3157895 0.68421053
1286 0.2530864 0.74691358
1288 0.7301587 0.26984127
1290 0.8832998 0.11670020
1292 0.7301587 0.26984127
1293 0.8832998 0.11670020
1294 0.8832998 0.11670020
1295 0.8832998 0.11670020
1297 0.3157895 0.68421053
1298 0.0952381 0.90476190
1299 0.7727273 0.22727273
1301 0.8832998 0.11670020
1302 0.7301587 0.26984127
1303 0.1313131 0.86868687
1304 0.8832998 0.11670020
1305 0.8832998 0.11670020
1306 0.9090909 0.09090909
1307 0.3142857 0.68571429
1308 0.7301587 0.26984127
1309 0.7586207 0.24137931
1311 0.8832998 0.11670020
1313 0.3157895 0.68421053
1317 0.8832998 0.11670020
1318 0.8832998 0.11670020
1319 0.9423077 0.05769231
1320 0.3142857 0.68571429
1321 0.8832998 0.11670020
1322 0.2530864 0.74691358
1323 0.8832998 0.11670020
1324 0.8832998 0.11670020
1325 0.8181818 0.18181818
1326 0.8832998 0.11670020
1327 0.8832998 0.11670020
1328 0.1313131 0.86868687
1329 0.8832998 0.11670020
1332 0.9423077 0.05769231
1333 0.8832998 0.11670020
1334 0.2530864 0.74691358
1336 0.8181818 0.18181818
1337 0.3142857 0.68571429
1338 0.8832998 0.11670020
1339 0.8832998 0.11670020
1340 0.8832998 0.11670020
1342 0.3157895 0.68421053
1343 0.8832998 0.11670020
1345 0.8832998 0.11670020
1346 0.1313131 0.86868687
1347 0.1313131 0.86868687
1348 0.7586207 0.24137931
1349 0.2530864 0.74691358
1351 0.8181818 0.18181818
1353 0.8832998 0.11670020
1354 0.8832998 0.11670020
1355 0.8832998 0.11670020
1356 0.1313131 0.86868687
1357 0.8832998 0.11670020
1358 0.8832998 0.11670020
1360 0.3157895 0.68421053
1361 0.7301587 0.26984127
1363 0.7727273 0.22727273
1365 0.3142857 0.68571429
1367 0.8832998 0.11670020
1368 0.3142857 0.68571429
1370 0.8832998 0.11670020
1371 0.8832998 0.11670020
1372 0.1313131 0.86868687
1373 0.3142857 0.68571429
1377 0.8832998 0.11670020
1379 0.7301587 0.26984127
1380 0.0952381 0.90476190
1381 0.8832998 0.11670020
1382 0.2530864 0.74691358
1384 0.1313131 0.86868687
1385 0.1313131 0.86868687
1386 0.1313131 0.86868687
1388 0.3142857 0.68571429
1390 0.1313131 0.86868687
1391 0.2530864 0.74691358
1392 0.2530864 0.74691358
1394 0.1313131 0.86868687
1396 0.2530864 0.74691358
1397 0.1313131 0.86868687
1400 0.1313131 0.86868687
1401 0.2530864 0.74691358
1402 0.1313131 0.86868687
1403 0.3157895 0.68421053
1405 0.1313131 0.86868687
1406 0.1313131 0.86868687
1408 0.1313131 0.86868687
1410 0.1313131 0.86868687
1411 0.1313131 0.86868687
1412 0.1313131 0.86868687
1413 0.2530864 0.74691358
1414 0.1313131 0.86868687
1415 0.3157895 0.68421053
1416 0.1313131 0.86868687
1417 0.2530864 0.74691358
1419 0.1313131 0.86868687
1421 0.2530864 0.74691358
1422 0.2530864 0.74691358
1425 0.7727273 0.22727273
1429 0.1313131 0.86868687
1430 0.7301587 0.26984127
1431 0.1313131 0.86868687
1433 0.1313131 0.86868687
1434 0.1313131 0.86868687
1437 0.2530864 0.74691358
1438 0.2530864 0.74691358
1440 0.2530864 0.74691358
1441 0.2530864 0.74691358
1442 0.1313131 0.86868687
1443 0.1313131 0.86868687
1444 0.3157895 0.68421053
1449 0.7727273 0.22727273
1451 0.1313131 0.86868687
1453 0.8832998 0.11670020
1454 0.1313131 0.86868687
1455 0.3157895 0.68421053
1456 0.2530864 0.74691358
1457 0.8832998 0.11670020
1458 0.8832998 0.11670020
1462 0.8832998 0.11670020
1463 0.8832998 0.11670020
1466 0.8832998 0.11670020
1467 0.1313131 0.86868687
1468 0.8832998 0.11670020
1469 0.1313131 0.86868687
1470 0.8832998 0.11670020
1472 0.8832998 0.11670020
1475 0.8832998 0.11670020
1476 0.8832998 0.11670020
1477 0.8181818 0.18181818
1478 0.7586207 0.24137931
1479 0.8832998 0.11670020
1480 0.8832998 0.11670020
1481 0.1313131 0.86868687
1482 0.8832998 0.11670020
1484 0.8832998 0.11670020
1485 0.2530864 0.74691358
1486 0.1313131 0.86868687
1487 0.8832998 0.11670020
1488 0.8832998 0.11670020
1490 0.2530864 0.74691358
1492 0.8832998 0.11670020
1493 0.7727273 0.22727273
1494 0.8832998 0.11670020
1497 0.2530864 0.74691358
1499 0.1313131 0.86868687
1500 0.1313131 0.86868687
1501 0.1313131 0.86868687
1502 0.7301587 0.26984127
1505 0.8832998 0.11670020
1506 0.8832998 0.11670020
1508 0.8832998 0.11670020
1516 0.8832998 0.11670020
1517 0.8832998 0.11670020
1519 0.8832998 0.11670020
1520 0.1313131 0.86868687
1523 0.8832998 0.11670020
1524 0.8832998 0.11670020
1525 0.7301587 0.26984127
1527 0.8832998 0.11670020
1528 0.8832998 0.11670020
1529 0.8832998 0.11670020
1530 0.8832998 0.11670020
1532 0.2530864 0.74691358
1533 0.8832998 0.11670020
1534 0.8832998 0.11670020
1535 0.8832998 0.11670020
1536 0.8832998 0.11670020
1537 0.8832998 0.11670020
1538 0.8832998 0.11670020
1539 0.3157895 0.68421053
1540 0.3157895 0.68421053
1541 0.1313131 0.86868687
1543 0.8832998 0.11670020
1544 0.8832998 0.11670020
1545 0.8832998 0.11670020
1547 0.8832998 0.11670020
1548 0.8832998 0.11670020
1549 0.8832998 0.11670020
1552 0.1313131 0.86868687
1553 0.3142857 0.68571429
1554 0.2530864 0.74691358
1556 0.8832998 0.11670020
1558 0.7586207 0.24137931
1559 0.8832998 0.11670020
1564 0.2530864 0.74691358
1565 0.2530864 0.74691358
1566 0.8832998 0.11670020
1568 0.2530864 0.74691358
1569 0.8832998 0.11670020
1570 0.8832998 0.11670020
1571 0.8832998 0.11670020
1576 0.8832998 0.11670020
1578 0.8832998 0.11670020
1579 0.8832998 0.11670020
1580 0.8832998 0.11670020
1581 0.7301587 0.26984127
1582 0.0952381 0.90476190
1583 0.8832998 0.11670020
1586 0.8832998 0.11670020
1587 0.8832998 0.11670020
1589 0.8832998 0.11670020
1590 0.8832998 0.11670020
1593 0.3142857 0.68571429
1594 0.8832998 0.11670020
1596 0.3142857 0.68571429
1597 0.3142857 0.68571429
1598 0.9090909 0.09090909
1601 0.8832998 0.11670020
1602 0.8832998 0.11670020
1604 0.8832998 0.11670020
1605 0.7301587 0.26984127
1606 0.1313131 0.86868687
1607 0.1313131 0.86868687
1608 0.1313131 0.86868687
1611 0.7301587 0.26984127
1612 0.8832998 0.11670020
1613 0.3157895 0.68421053
1614 0.8832998 0.11670020
1615 0.8832998 0.11670020
1617 0.8832998 0.11670020
1620 0.8832998 0.11670020
1621 0.8832998 0.11670020
1622 0.3142857 0.68571429
1623 0.1313131 0.86868687
1624 0.2530864 0.74691358
1625 0.2530864 0.74691358
1626 0.8832998 0.11670020
1627 0.8832998 0.11670020
1628 0.3142857 0.68571429
1630 0.7301587 0.26984127
1631 0.7301587 0.26984127
1632 0.1313131 0.86868687
1633 0.8832998 0.11670020
1634 0.1313131 0.86868687
1635 0.3142857 0.68571429
1636 0.1313131 0.86868687
1638 0.1313131 0.86868687
1639 0.1313131 0.86868687
1641 0.1313131 0.86868687
1642 0.1313131 0.86868687
1643 0.1313131 0.86868687
1644 0.1313131 0.86868687
1646 0.1313131 0.86868687
1647 0.1313131 0.86868687
1649 0.1313131 0.86868687
1650 0.1313131 0.86868687
1651 0.1313131 0.86868687
1652 0.1313131 0.86868687
1653 0.1313131 0.86868687
1655 0.1313131 0.86868687
1661 0.1313131 0.86868687
1663 0.1313131 0.86868687
1664 0.1313131 0.86868687
1666 0.1313131 0.86868687
1667 0.1313131 0.86868687
1668 0.7586207 0.24137931
1671 0.8832998 0.11670020
1673 0.1313131 0.86868687
1674 0.1313131 0.86868687
1675 0.1313131 0.86868687
1676 0.1313131 0.86868687
1678 0.1313131 0.86868687
1679 0.1313131 0.86868687
1681 0.1313131 0.86868687
1682 0.1313131 0.86868687
1683 0.7586207 0.24137931
1684 0.1313131 0.86868687
1685 0.8832998 0.11670020
1686 0.1313131 0.86868687
1687 0.1313131 0.86868687
1688 0.1313131 0.86868687
1691 0.1313131 0.86868687
1698 0.1313131 0.86868687
1699 0.1313131 0.86868687
1700 0.1313131 0.86868687
1701 0.1313131 0.86868687
1702 0.1313131 0.86868687
1703 0.1313131 0.86868687
1705 0.7301587 0.26984127
1706 0.1313131 0.86868687
1707 0.1313131 0.86868687
1708 0.1313131 0.86868687
1709 0.1313131 0.86868687
1711 0.1313131 0.86868687
1712 0.1313131 0.86868687
1713 0.1313131 0.86868687
1714 0.1313131 0.86868687
1715 0.1313131 0.86868687
1716 0.1313131 0.86868687
1718 0.8832998 0.11670020
1719 0.1313131 0.86868687
1720 0.1313131 0.86868687
1721 0.1313131 0.86868687
1723 0.1313131 0.86868687
1724 0.1313131 0.86868687
1725 0.8832998 0.11670020
1727 0.1313131 0.86868687
1728 0.1313131 0.86868687
1729 0.1313131 0.86868687
1732 0.1313131 0.86868687
1733 0.1313131 0.86868687
1734 0.1313131 0.86868687
1735 0.1313131 0.86868687
1738 0.1313131 0.86868687
1739 0.1313131 0.86868687
1740 0.1313131 0.86868687
1741 0.1313131 0.86868687
1742 0.1313131 0.86868687
1743 0.1313131 0.86868687
1744 0.1313131 0.86868687
1747 0.1313131 0.86868687
1749 0.1313131 0.86868687
1750 0.1313131 0.86868687
1751 0.1313131 0.86868687
1753 0.1313131 0.86868687
1755 0.1313131 0.86868687
1756 0.2530864 0.74691358
1757 0.1313131 0.86868687
1758 0.1313131 0.86868687
1760 0.1313131 0.86868687
1762 0.1313131 0.86868687
1764 0.1313131 0.86868687
1765 0.1313131 0.86868687
1767 0.1313131 0.86868687
1770 0.1313131 0.86868687
1771 0.1313131 0.86868687
1772 0.1313131 0.86868687
1773 0.2530864 0.74691358
1774 0.2530864 0.74691358
1775 0.1313131 0.86868687
1778 0.1313131 0.86868687
1779 0.1313131 0.86868687
1780 0.1313131 0.86868687
1781 0.1313131 0.86868687
1782 0.1313131 0.86868687
1783 0.1313131 0.86868687
1784 0.1313131 0.86868687
1786 0.1313131 0.86868687
1790 0.1313131 0.86868687
1791 0.3157895 0.68421053
1793 0.1313131 0.86868687
1794 0.1313131 0.86868687
1795 0.1313131 0.86868687
1797 0.1313131 0.86868687
1798 0.1313131 0.86868687
1799 0.1313131 0.86868687
1801 0.1313131 0.86868687
1802 0.1313131 0.86868687
1803 0.1313131 0.86868687
1804 0.1313131 0.86868687
1805 0.7727273 0.22727273
1806 0.1313131 0.86868687
1807 0.1313131 0.86868687
1808 0.8832998 0.11670020
1809 0.1313131 0.86868687
1810 0.1313131 0.86868687
1811 0.1313131 0.86868687
1812 0.1313131 0.86868687
1813 0.1313131 0.86868687
1814 0.1313131 0.86868687
1815 0.1313131 0.86868687
1817 0.1313131 0.86868687
1818 0.1313131 0.86868687
1819 0.1313131 0.86868687
1821 0.8832998 0.11670020
1822 0.1313131 0.86868687
1824 0.1313131 0.86868687
1825 0.1313131 0.86868687
1826 0.1313131 0.86868687
1827 0.1313131 0.86868687
1828 0.1313131 0.86868687
1829 0.7301587 0.26984127
1830 0.1313131 0.86868687
1831 0.1313131 0.86868687
1832 0.1313131 0.86868687
1833 0.1313131 0.86868687
1834 0.1313131 0.86868687
1835 0.1313131 0.86868687
1836 0.1313131 0.86868687
1837 0.1313131 0.86868687
1839 0.1313131 0.86868687
1840 0.1313131 0.86868687
1842 0.8832998 0.11670020
1843 0.8832998 0.11670020
1844 0.1313131 0.86868687
1845 0.1313131 0.86868687
1846 0.1313131 0.86868687
1847 0.1313131 0.86868687
1848 0.1313131 0.86868687
1850 0.1313131 0.86868687
1851 0.1313131 0.86868687
1852 0.2530864 0.74691358
1853 0.1313131 0.86868687
1854 0.8832998 0.11670020
1855 0.8832998 0.11670020
1856 0.8832998 0.11670020
1858 0.8832998 0.11670020
1859 0.8832998 0.11670020
1860 0.8832998 0.11670020
> str(test)
'data.frame':   558 obs. of  367 variables:
 $ Tadjuv          : num  0 0 0 1 0 0 1 0 1 0 ...
 $ Tadvanc         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tbreast         : num  0 0 1 1 1 1 1 1 1 0 ...
 $ Tcancer         : num  1 0 1 1 1 0 1 1 1 0 ...
 $ Tchemotherapi   : num  0 0 1 0 0 1 1 1 0 0 ...
 $ Tclinic         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tcombin         : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Tcompar         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tcyclophosphamid: num  0 0 0 0 2 0 0 0 0 0 ...
 $ Tdocetaxel      : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tdoxorubicin    : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Tearli          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Teffect         : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Tgroup          : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Tiii            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tmetastat       : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Tpatient        : num  0 0 1 1 0 0 0 1 0 0 ...
 $ Tphase          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Tplus           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Tpostmenopaus   : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Trandom         : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Trandomis       : num  0 0 0 1 1 0 0 1 1 0 ...
 $ Trespons        : num  0 0 0 0 0 1 0 1 1 0 ...
 $ Tresult         : num  0 0 0 0 0 0 1 1 0 0 ...
 $ Tstudi          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Ttamoxifen      : num  0 0 0 1 0 0 0 0 1 1 ...
 $ Ttherapi        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Ttreatment      : num  1 0 1 0 0 0 0 0 0 0 ...
 $ Ttrial          : num  0 0 1 1 0 0 0 1 1 0 ...
 $ Tversus         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Twomen          : num  0 0 0 0 1 0 0 0 0 0 ...
 $ A0001           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ A001            : num  0 0 0 0 0 1 0 0 0 0 ...
 $ A005            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ A100            : num  0 1 0 0 0 0 0 0 0 0 ...
 $ A500            : num  0 0 2 0 0 0 0 0 1 0 ...
 $ A5fluorouracil  : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aaccord         : num  0 0 0 0 0 1 0 0 1 0 ...
 $ Aachiev         : num  0 0 0 1 0 1 0 0 0 0 ...
 $ Aactiv          : num  0 2 0 0 0 0 0 2 0 0 ...
 $ Aaddit          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aadjuv          : num  0 0 0 4 1 0 0 0 0 0 ...
 $ Aadminist       : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Aadministr      : num  0 0 0 0 1 0 0 0 0 0 ...
 $ Aadvanc         : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Aadvers         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aage            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aagent          : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Aaim            : num  0 0 0 0 0 1 0 0 1 0 ...
 $ Aalon           : num  0 0 0 3 0 0 0 0 0 0 ...
 $ Aalso           : num  0 0 0 2 0 0 0 1 0 0 ...
 $ Aalthough       : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aamong          : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Aanalys         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanalysi        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanalyz         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aandor          : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aanthracyclin   : num  0 0 0 0 0 2 0 0 0 0 ...
 $ Aappear         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aarm            : num  0 0 2 0 3 5 0 0 0 0 ...
 $ Aaromatas       : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aassess         : num  0 2 0 0 1 0 0 1 2 0 ...
 $ Aassign         : num  0 0 0 1 0 1 0 0 0 0 ...
 $ Aassoci         : num  0 0 0 2 0 0 0 0 0 0 ...
 $ Aavail          : num  0 0 0 0 0 0 0 0 1 0 ...
 $ Aaxillari       : num  0 0 0 1 0 0 0 0 0 0 ...
 $ Abackground     : num  0 0 1 1 0 0 0 0 1 0 ...
 $ Abase           : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Abaselin        : num  0 0 0 0 0 1 0 0 0 0 ...
 $ Abenefit        : num  0 0 2 1 0 0 0 0 0 0 ...
 $ Abetter         : num  0 0 1 0 0 0 0 1 0 0 ...
 $ Abone           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Abreast         : num  0 2 3 2 2 2 0 3 5 0 ...
 $ Acan            : num  0 0 0 1 0 1 0 1 1 0 ...
 $ Acancer         : num  0 0 3 3 3 0 0 3 5 0 ...
 $ Acarcinoma      : num  0 5 0 0 0 2 0 0 2 0 ...
 $ Acase           : num  0 11 1 0 0 0 0 0 0 0 ...
 $ Acaus           : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acell           : num  0 3 0 0 0 0 0 1 0 0 ...
 $ Achang          : num  0 0 0 0 1 1 0 0 0 0 ...
 $ Acharacterist   : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Achemotherapi   : num  0 0 3 1 3 4 0 5 0 0 ...
 $ Aclinic         : num  0 1 0 0 0 0 0 3 2 0 ...
 $ Acmf            : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acombin         : num  0 0 6 1 3 0 0 0 1 0 ...
 $ Acommon         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acompar         : num  0 0 0 1 2 0 0 2 0 0 ...
 $ Acomparison     : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acomplet        : num  0 0 1 0 0 2 0 3 0 0 ...
 $ Aconclus        : num  0 0 1 0 0 0 0 0 1 0 ...
 $ Aconduct        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconfid         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconfirm        : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsid         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Aconsist        : num  0 1 0 0 0 0 0 0 0 0 ...
 $ Acontinu        : num  0 0 1 0 0 0 0 0 0 0 ...
 $ Acontrol        : num  0 1 0 1 0 0 0 1 1 0 ...
 $ Acorrel         : num  0 0 0 0 0 0 0 0 0 0 ...
 $ Acours          : num  0 0 0 0 1 0 0 0 0 0 ...
  [list output truncated]
> pred.prob = pred[,2]
> pred.prob
         3          4          6          7          8         10         11 
0.86868687 0.86868687 0.05769231 0.74691358 0.11670020 0.86868687 0.68421053 
        12         14         16         19         20         22         23 
0.68571429 0.26984127 0.74691358 0.68571429 0.11670020 0.68571429 0.86868687 
        24         25         26         27         28         30         31 
0.11670020 0.68421053 0.24137931 0.24137931 0.86868687 0.11670020 0.11670020 
        32         33         35         37         38         39         41 
0.11670020 0.68571429 0.74691358 0.86868687 0.86868687 0.11670020 0.74691358 
        42         43         44         45         46         47         48 
0.11670020 0.11670020 0.68571429 0.68421053 0.86868687 0.11670020 0.24137931 
        49         50         51         53         54         56         58 
0.05769231 0.11670020 0.11670020 0.86868687 0.11670020 0.11670020 0.86868687 
        59         60         61         62         64         65         66 
0.74691358 0.86868687 0.74691358 0.86868687 0.11670020 0.86868687 0.11670020 
        67         68         69         70         71         73         74 
0.86868687 0.86868687 0.11670020 0.11670020 0.86868687 0.86868687 0.11670020 
        75         77         78         79         80         81         85 
0.74691358 0.11670020 0.05769231 0.74691358 0.86868687 0.26984127 0.86868687 
        87         88         89         91         92         93         94 
0.11670020 0.11670020 0.86868687 0.74691358 0.74691358 0.11670020 0.26984127 
        95         97         98         99        100        101        103 
0.11670020 0.09090909 0.11670020 0.11670020 0.11670020 0.86868687 0.11670020 
       105        106        107        108        109        111        113 
0.11670020 0.86868687 0.86868687 0.74691358 0.11670020 0.74691358 0.86868687 
       114        117        118        119        120        123        125 
0.68421053 0.86868687 0.11670020 0.11670020 0.05769231 0.74691358 0.86868687 
       126        128        129        130        131        132        133 
0.74691358 0.11670020 0.11670020 0.11670020 0.74691358 0.11670020 0.11670020 
       134        135        137        138        140        141        143 
0.11670020 0.86868687 0.11670020 0.05769231 0.11670020 0.86868687 0.11670020 
       146        147        148        149        150        151        153 
0.74691358 0.24137931 0.05769231 0.11670020 0.11670020 0.74691358 0.68421053 
       155        156        158        159        160        161        162 
0.11670020 0.09090909 0.68571429 0.26984127 0.11670020 0.86868687 0.86868687 
       164        165        167        168        170        171        173 
0.86868687 0.05769231 0.90476190 0.11670020 0.24137931 0.18181818 0.74691358 
       174        177        178        179        182        183        185 
0.22727273 0.74691358 0.26984127 0.11670020 0.11670020 0.11670020 0.11670020 
       186        187        188        189        190        191        192 
0.74691358 0.11670020 0.74691358 0.11670020 0.74691358 0.11670020 0.86868687 
       195        196        197        198        199        200        202 
0.86868687 0.11670020 0.11670020 0.11670020 0.11670020 0.74691358 0.86868687 
       203        204        205        206        207        210        211 
0.24137931 0.68421053 0.68571429 0.26984127 0.86868687 0.24137931 0.11670020 
       212        214        215        217        218        219        220 
0.74691358 0.68421053 0.11670020 0.74691358 0.74691358 0.05769231 0.74691358 
       221        224        225        226        227        228        229 
0.11670020 0.11670020 0.86868687 0.24137931 0.86868687 0.86868687 0.11670020 
       230        231        232        233        234        235        236 
0.11670020 0.11670020 0.11670020 0.86868687 0.74691358 0.26984127 0.11670020 
       238        240        241        243        246        248        249 
0.11670020 0.74691358 0.05769231 0.11670020 0.11670020 0.11670020 0.74691358 
       250        251        253        254        255        257        258 
0.11670020 0.74691358 0.26984127 0.22727273 0.68571429 0.74691358 0.11670020 
       259        260        261        262        265        267        268 
0.11670020 0.11670020 0.11670020 0.11670020 0.86868687 0.86868687 0.11670020 
       269        270        272        273        274        275        276 
0.26984127 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 
       278        279        282        283        287        288        289 
0.11670020 0.11670020 0.74691358 0.74691358 0.11670020 0.24137931 0.74691358 
       290        292        293        294        296        297        299 
0.11670020 0.11670020 0.11670020 0.86868687 0.11670020 0.74691358 0.24137931 
       302        303        304        305        306        307        308 
0.11670020 0.05769231 0.05769231 0.05769231 0.11670020 0.11670020 0.11670020 
       310        313        314        316        317        319        320 
0.74691358 0.68421053 0.74691358 0.86868687 0.11670020 0.05769231 0.11670020 
       322        323        324        325        328        329        330 
0.11670020 0.24137931 0.11670020 0.22727273 0.74691358 0.05769231 0.11670020 
       333        334        335        338        340        342        343 
0.11670020 0.74691358 0.11670020 0.74691358 0.86868687 0.09090909 0.11670020 
       344        345        350        351        352        353        354 
0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.05769231 0.11670020 
       356        358        360        361        362        363        364 
0.11670020 0.11670020 0.86868687 0.05769231 0.11670020 0.68571429 0.11670020 
       365        367        368        369        370        371        372 
0.11670020 0.86868687 0.86868687 0.26984127 0.86868687 0.11670020 0.11670020 
       374        375        376        377        378        380        385 
0.68571429 0.11670020 0.22727273 0.11670020 0.11670020 0.24137931 0.74691358 
       388        389        390        393        394        395        397 
0.86868687 0.05769231 0.24137931 0.05769231 0.11670020 0.68571429 0.22727273 
       398        399        400        401        402        404        405 
0.11670020 0.11670020 0.26984127 0.86868687 0.86868687 0.24137931 0.18181818 
       406        407        408        411        412        413        416 
0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.74691358 0.11670020 
       417        418        419        420        421        422        423 
0.05769231 0.24137931 0.05769231 0.11670020 0.11670020 0.90476190 0.11670020 
       425        426        428        430        431        433        434 
0.11670020 0.11670020 0.11670020 0.68571429 0.86868687 0.86868687 0.11670020 
       435        436        437        438        440        441        442 
0.68571429 0.68571429 0.11670020 0.11670020 0.11670020 0.86868687 0.90476190 
       443        444        445        446        449        454        455 
0.86868687 0.86868687 0.11670020 0.11670020 0.11670020 0.90476190 0.11670020 
       457        458        459        461        462        463        464 
0.11670020 0.11670020 0.74691358 0.26984127 0.74691358 0.26984127 0.74691358 
       467        468        469        470        471        473        474 
0.26984127 0.11670020 0.11670020 0.11670020 0.24137931 0.74691358 0.11670020 
       475        476        477        478        479        483        485 
0.11670020 0.26984127 0.11670020 0.24137931 0.09090909 0.11670020 0.24137931 
       486        488        489        490        491        493        494 
0.05769231 0.24137931 0.86868687 0.68421053 0.68571429 0.86868687 0.68571429 
       495        499        500        507        508        509        510 
0.68421053 0.68571429 0.74691358 0.11670020 0.11670020 0.11670020 0.86868687 
       511        514        515        516        517        518        519 
0.11670020 0.05769231 0.11670020 0.11670020 0.86868687 0.11670020 0.11670020 
       520        521        524        526        529        530        531 
0.74691358 0.74691358 0.26984127 0.11670020 0.11670020 0.74691358 0.11670020 
       532        533        535        538        541        542        543 
0.74691358 0.68571429 0.22727273 0.11670020 0.24137931 0.05769231 0.11670020 
       544        545        546        547        549        550        551 
0.11670020 0.86868687 0.09090909 0.11670020 0.26984127 0.68571429 0.11670020 
       552        553        554        555        557        559        560 
0.74691358 0.11670020 0.24137931 0.11670020 0.11670020 0.11670020 0.74691358 
       561        562        565        566        571        573        575 
0.11670020 0.11670020 0.11670020 0.68571429 0.74691358 0.11670020 0.74691358 
       576        577        579        582        583        584        585 
0.11670020 0.11670020 0.68571429 0.11670020 0.74691358 0.86868687 0.11670020 
       586        587        588        589        590        591        592 
0.11670020 0.11670020 0.11670020 0.86868687 0.86868687 0.90476190 0.11670020 
       593        595        596        597        598        599        600 
0.22727273 0.68571429 0.86868687 0.11670020 0.11670020 0.11670020 0.68571429 
       601        602        603        604        607        610        612 
0.26984127 0.74691358 0.74691358 0.11670020 0.11670020 0.11670020 0.22727273 
       615        616        617        618        622        624        626 
0.26984127 0.05769231 0.74691358 0.24137931 0.11670020 0.11670020 0.11670020 
       627        628        632        634        635        636        637 
0.11670020 0.11670020 0.86868687 0.05769231 0.68571429 0.05769231 0.68571429 
       638        639        640        643        645        646        648 
0.24137931 0.26984127 0.05769231 0.74691358 0.18181818 0.11670020 0.11670020 
       651        652        653        655        656        659        661 
0.11670020 0.24137931 0.24137931 0.74691358 0.86868687 0.24137931 0.11670020 
       662        664        666        667        668        669        670 
0.05769231 0.24137931 0.24137931 0.11670020 0.05769231 0.90476190 0.11670020 
       671        672        674        676        677        678        679 
0.68571429 0.74691358 0.05769231 0.74691358 0.74691358 0.11670020 0.86868687 
       681        682        683        685        686        687        689 
0.68571429 0.11670020 0.74691358 0.74691358 0.11670020 0.86868687 0.11670020 
       690        691        692        693        694        699        700 
0.74691358 0.11670020 0.11670020 0.74691358 0.86868687 0.11670020 0.68571429 
       701        703        704        705        707        709        710 
0.05769231 0.11670020 0.86868687 0.11670020 0.86868687 0.74691358 0.11670020 
       712        713        715        716        717        718        719 
0.05769231 0.11670020 0.86868687 0.11670020 0.74691358 0.11670020 0.74691358 
       721        722        727        728        729        730        731 
0.11670020 0.11670020 0.74691358 0.24137931 0.11670020 0.11670020 0.11670020 
       732        733        737        738        739        740        741 
0.11670020 0.74691358 0.74691358 0.90476190 0.11670020 0.11670020 0.90476190 
       742        744        745        747        748        749        750 
0.11670020 0.86868687 0.11670020 0.11670020 0.11670020 0.86868687 0.24137931 
       752        753        754        755        756        757        758 
0.11670020 0.86868687 0.86868687 0.11670020 0.26984127 0.18181818 0.11670020 
       759        760        761        762        763        764        766 
0.86868687 0.68421053 0.22727273 0.11670020 0.86868687 0.22727273 0.74691358 
       767        768        770        771        772        773        774 
0.24137931 0.68421053 0.74691358 0.68571429 0.11670020 0.05769231 0.11670020 
       776        777        779        780        781        782        784 
0.24137931 0.86868687 0.68571429 0.68571429 0.74691358 0.11670020 0.05769231 
       788        789        790        791        792        793        794 
0.11670020 0.05769231 0.11670020 0.74691358 0.90476190 0.11670020 0.24137931 
       795        797        798        799        803        804        805 
0.11670020 0.11670020 0.05769231 0.11670020 0.11670020 0.11670020 0.11670020 
       806        807        810        811        812        813        814 
0.90476190 0.11670020 0.11670020 0.11670020 0.11670020 0.86868687 0.86868687 
       817        818        819        822        825        827        828 
0.74691358 0.11670020 0.11670020 0.24137931 0.68571429 0.11670020 0.05769231 
       829        831        832        834        836        837        838 
0.11670020 0.11670020 0.11670020 0.24137931 0.74691358 0.74691358 0.74691358 
       839        840        841        842        843        845        846 
0.11670020 0.68571429 0.68421053 0.26984127 0.11670020 0.68421053 0.11670020 
       847        848        852        853        856        857        859 
0.11670020 0.11670020 0.05769231 0.86868687 0.68571429 0.11670020 0.68571429 
       860        861        862        863        864        865        866 
0.68421053 0.74691358 0.11670020 0.90476190 0.11670020 0.11670020 0.11670020 
       869        870        872        874        876        877        879 
0.11670020 0.11670020 0.11670020 0.74691358 0.86868687 0.11670020 0.68571429 
       880        881        883        884        885        887        889 
0.22727273 0.11670020 0.74691358 0.26984127 0.68571429 0.11670020 0.05769231 
       890        891        892        893        894        897        899 
0.68571429 0.86868687 0.11670020 0.11670020 0.05769231 0.11670020 0.11670020 
       900        901        902        903        904        905        907 
0.11670020 0.11670020 0.74691358 0.86868687 0.74691358 0.74691358 0.26984127 
       910        911        914        915        916        917        918 
0.11670020 0.74691358 0.74691358 0.24137931 0.11670020 0.68571429 0.11670020 
       919        920        922        923        924        926        927 
0.26984127 0.68571429 0.74691358 0.11670020 0.74691358 0.24137931 0.11670020 
       928        929        930        931        932        933        936 
0.74691358 0.11670020 0.68421053 0.24137931 0.86868687 0.90476190 0.74691358 
       937        939        940        941        943        945        948 
0.24137931 0.11670020 0.74691358 0.90476190 0.11670020 0.26984127 0.11670020 
       949        951        952        953        954        955        956 
0.11670020 0.68571429 0.26984127 0.11670020 0.11670020 0.11670020 0.26984127 
       957        958        959        962        963        964        966 
0.74691358 0.68571429 0.11670020 0.86868687 0.74691358 0.26984127 0.74691358 
       968        969        970        972        973        974        975 
0.86868687 0.86868687 0.11670020 0.24137931 0.74691358 0.26984127 0.11670020 
       976        977        978        983        984        985        988 
0.11670020 0.11670020 0.24137931 0.74691358 0.68571429 0.74691358 0.26984127 
       989        990        991        992        993        994        995 
0.11670020 0.24137931 0.74691358 0.11670020 0.22727273 0.11670020 0.86868687 
       997       1001       1002       1003       1004       1005       1006 
0.09090909 0.74691358 0.24137931 0.68421053 0.74691358 0.11670020 0.11670020 
      1008       1009       1011       1012       1014       1015       1016 
0.68571429 0.11670020 0.22727273 0.11670020 0.11670020 0.05769231 0.26984127 
      1019       1020       1022       1023       1024       1026       1027 
0.11670020 0.11670020 0.86868687 0.11670020 0.11670020 0.11670020 0.74691358 
      1029       1032       1033       1034       1036       1037       1038 
0.11670020 0.26984127 0.11670020 0.05769231 0.11670020 0.74691358 0.24137931 
      1039       1042       1043       1045       1047       1048       1049 
0.26984127 0.74691358 0.68571429 0.05769231 0.05769231 0.26984127 0.11670020 
      1050       1051       1052       1054       1055       1056       1057 
0.11670020 0.11670020 0.11670020 0.74691358 0.86868687 0.11670020 0.11670020 
      1058       1059       1060       1061       1062       1063       1065 
0.11670020 0.86868687 0.68571429 0.11670020 0.11670020 0.11670020 0.11670020 
      1066       1067       1069       1070       1071       1073       1074 
0.68421053 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.24137931 
      1075       1076       1081       1085       1086       1088       1089 
0.68421053 0.11670020 0.24137931 0.74691358 0.24137931 0.74691358 0.74691358 
      1090       1091       1092       1093       1094       1096       1097 
0.26984127 0.74691358 0.11670020 0.86868687 0.11670020 0.68571429 0.90476190 
      1098       1099       1101       1104       1105       1106       1107 
0.11670020 0.11670020 0.68571429 0.11670020 0.05769231 0.68571429 0.86868687 
      1108       1110       1111       1112       1114       1115       1117 
0.05769231 0.11670020 0.68571429 0.11670020 0.86868687 0.26984127 0.86868687 
      1118       1119       1120       1122       1124       1125       1127 
0.86868687 0.74691358 0.68571429 0.68421053 0.86868687 0.86868687 0.11670020 
      1128       1129       1130       1131       1132       1133       1134 
0.68421053 0.11670020 0.22727273 0.09090909 0.74691358 0.86868687 0.09090909 
      1135       1137       1138       1139       1140       1141       1142 
0.11670020 0.11670020 0.11670020 0.74691358 0.11670020 0.26984127 0.11670020 
      1143       1144       1145       1146       1147       1148       1149 
0.11670020 0.24137931 0.11670020 0.26984127 0.26984127 0.11670020 0.74691358 
      1150       1151       1152       1154       1155       1156       1157 
0.11670020 0.86868687 0.24137931 0.74691358 0.74691358 0.11670020 0.68571429 
      1158       1159       1160       1161       1162       1163       1165 
0.11670020 0.74691358 0.05769231 0.11670020 0.11670020 0.11670020 0.74691358 
      1168       1170       1171       1172       1177       1178       1179 
0.18181818 0.11670020 0.11670020 0.11670020 0.68571429 0.86868687 0.74691358 
      1180       1181       1182       1183       1184       1185       1189 
0.11670020 0.68421053 0.11670020 0.26984127 0.11670020 0.26984127 0.11670020 
      1194       1197       1198       1202       1203       1204       1205 
0.74691358 0.11670020 0.05769231 0.11670020 0.68571429 0.11670020 0.18181818 
      1208       1209       1210       1211       1213       1214       1217 
0.11670020 0.11670020 0.68421053 0.11670020 0.26984127 0.11670020 0.24137931 
      1218       1220       1221       1222       1223       1225       1226 
0.11670020 0.90476190 0.26984127 0.74691358 0.68421053 0.24137931 0.90476190 
      1228       1229       1232       1233       1234       1235       1236 
0.74691358 0.11670020 0.11670020 0.74691358 0.86868687 0.11670020 0.74691358 
      1237       1240       1241       1242       1243       1244       1246 
0.11670020 0.86868687 0.05769231 0.18181818 0.11670020 0.11670020 0.74691358 
      1247       1248       1250       1251       1254       1255       1256 
0.26984127 0.11670020 0.22727273 0.90476190 0.11670020 0.11670020 0.74691358 
      1257       1259       1260       1261       1262       1263       1264 
0.68571429 0.11670020 0.86868687 0.11670020 0.26984127 0.68421053 0.11670020 
      1265       1266       1267       1268       1269       1270       1272 
0.26984127 0.05769231 0.11670020 0.11670020 0.09090909 0.74691358 0.11670020 
      1273       1274       1275       1276       1277       1278       1279 
0.11670020 0.11670020 0.11670020 0.86868687 0.11670020 0.86868687 0.24137931 
      1280       1281       1283       1284       1285       1286       1288 
0.86868687 0.90476190 0.22727273 0.68571429 0.68421053 0.74691358 0.26984127 
      1290       1292       1293       1294       1295       1297       1298 
0.11670020 0.26984127 0.11670020 0.11670020 0.11670020 0.68421053 0.90476190 
      1299       1301       1302       1303       1304       1305       1306 
0.22727273 0.11670020 0.26984127 0.86868687 0.11670020 0.11670020 0.09090909 
      1307       1308       1309       1311       1313       1317       1318 
0.68571429 0.26984127 0.24137931 0.11670020 0.68421053 0.11670020 0.11670020 
      1319       1320       1321       1322       1323       1324       1325 
0.05769231 0.68571429 0.11670020 0.74691358 0.11670020 0.11670020 0.18181818 
      1326       1327       1328       1329       1332       1333       1334 
0.11670020 0.11670020 0.86868687 0.11670020 0.05769231 0.11670020 0.74691358 
      1336       1337       1338       1339       1340       1342       1343 
0.18181818 0.68571429 0.11670020 0.11670020 0.11670020 0.68421053 0.11670020 
      1345       1346       1347       1348       1349       1351       1353 
0.11670020 0.86868687 0.86868687 0.24137931 0.74691358 0.18181818 0.11670020 
      1354       1355       1356       1357       1358       1360       1361 
0.11670020 0.11670020 0.86868687 0.11670020 0.11670020 0.68421053 0.26984127 
      1363       1365       1367       1368       1370       1371       1372 
0.22727273 0.68571429 0.11670020 0.68571429 0.11670020 0.11670020 0.86868687 
      1373       1377       1379       1380       1381       1382       1384 
0.68571429 0.11670020 0.26984127 0.90476190 0.11670020 0.74691358 0.86868687 
      1385       1386       1388       1390       1391       1392       1394 
0.86868687 0.86868687 0.68571429 0.86868687 0.74691358 0.74691358 0.86868687 
      1396       1397       1400       1401       1402       1403       1405 
0.74691358 0.86868687 0.86868687 0.74691358 0.86868687 0.68421053 0.86868687 
      1406       1408       1410       1411       1412       1413       1414 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.74691358 0.86868687 
      1415       1416       1417       1419       1421       1422       1425 
0.68421053 0.86868687 0.74691358 0.86868687 0.74691358 0.74691358 0.22727273 
      1429       1430       1431       1433       1434       1437       1438 
0.86868687 0.26984127 0.86868687 0.86868687 0.86868687 0.74691358 0.74691358 
      1440       1441       1442       1443       1444       1449       1451 
0.74691358 0.74691358 0.86868687 0.86868687 0.68421053 0.22727273 0.86868687 
      1453       1454       1455       1456       1457       1458       1462 
0.11670020 0.86868687 0.68421053 0.74691358 0.11670020 0.11670020 0.11670020 
      1463       1466       1467       1468       1469       1470       1472 
0.11670020 0.11670020 0.86868687 0.11670020 0.86868687 0.11670020 0.11670020 
      1475       1476       1477       1478       1479       1480       1481 
0.11670020 0.11670020 0.18181818 0.24137931 0.11670020 0.11670020 0.86868687 
      1482       1484       1485       1486       1487       1488       1490 
0.11670020 0.11670020 0.74691358 0.86868687 0.11670020 0.11670020 0.74691358 
      1492       1493       1494       1497       1499       1500       1501 
0.11670020 0.22727273 0.11670020 0.74691358 0.86868687 0.86868687 0.86868687 
      1502       1505       1506       1508       1516       1517       1519 
0.26984127 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 
      1520       1523       1524       1525       1527       1528       1529 
0.86868687 0.11670020 0.11670020 0.26984127 0.11670020 0.11670020 0.11670020 
      1530       1532       1533       1534       1535       1536       1537 
0.11670020 0.74691358 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 
      1538       1539       1540       1541       1543       1544       1545 
0.11670020 0.68421053 0.68421053 0.86868687 0.11670020 0.11670020 0.11670020 
      1547       1548       1549       1552       1553       1554       1556 
0.11670020 0.11670020 0.11670020 0.86868687 0.68571429 0.74691358 0.11670020 
      1558       1559       1564       1565       1566       1568       1569 
0.24137931 0.11670020 0.74691358 0.74691358 0.11670020 0.74691358 0.11670020 
      1570       1571       1576       1578       1579       1580       1581 
0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.26984127 
      1582       1583       1586       1587       1589       1590       1593 
0.90476190 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.68571429 
      1594       1596       1597       1598       1601       1602       1604 
0.11670020 0.68571429 0.68571429 0.09090909 0.11670020 0.11670020 0.11670020 
      1605       1606       1607       1608       1611       1612       1613 
0.26984127 0.86868687 0.86868687 0.86868687 0.26984127 0.11670020 0.68421053 
      1614       1615       1617       1620       1621       1622       1623 
0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.68571429 0.86868687 
      1624       1625       1626       1627       1628       1630       1631 
0.74691358 0.74691358 0.11670020 0.11670020 0.68571429 0.26984127 0.26984127 
      1632       1633       1634       1635       1636       1638       1639 
0.86868687 0.11670020 0.86868687 0.68571429 0.86868687 0.86868687 0.86868687 
      1641       1642       1643       1644       1646       1647       1649 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1650       1651       1652       1653       1655       1661       1663 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1664       1666       1667       1668       1671       1673       1674 
0.86868687 0.86868687 0.86868687 0.24137931 0.11670020 0.86868687 0.86868687 
      1675       1676       1678       1679       1681       1682       1683 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.24137931 
      1684       1685       1686       1687       1688       1691       1698 
0.86868687 0.11670020 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1699       1700       1701       1702       1703       1705       1706 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.26984127 0.86868687 
      1707       1708       1709       1711       1712       1713       1714 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1715       1716       1718       1719       1720       1721       1723 
0.86868687 0.86868687 0.11670020 0.86868687 0.86868687 0.86868687 0.86868687 
      1724       1725       1727       1728       1729       1732       1733 
0.86868687 0.11670020 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1734       1735       1738       1739       1740       1741       1742 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1743       1744       1747       1749       1750       1751       1753 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1755       1756       1757       1758       1760       1762       1764 
0.86868687 0.74691358 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1765       1767       1770       1771       1772       1773       1774 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.74691358 0.74691358 
      1775       1778       1779       1780       1781       1782       1783 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1784       1786       1790       1791       1793       1794       1795 
0.86868687 0.86868687 0.86868687 0.68421053 0.86868687 0.86868687 0.86868687 
      1797       1798       1799       1801       1802       1803       1804 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1805       1806       1807       1808       1809       1810       1811 
0.22727273 0.86868687 0.86868687 0.11670020 0.86868687 0.86868687 0.86868687 
      1812       1813       1814       1815       1817       1818       1819 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1821       1822       1824       1825       1826       1827       1828 
0.11670020 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1829       1830       1831       1832       1833       1834       1835 
0.26984127 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 
      1836       1837       1839       1840       1842       1843       1844 
0.86868687 0.86868687 0.86868687 0.86868687 0.11670020 0.11670020 0.86868687 
      1845       1846       1847       1848       1850       1851       1852 
0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.86868687 0.74691358 
      1853       1854       1855       1856       1858       1859       1860 
0.86868687 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 0.11670020 
> max(pred.prob)
[1] 0.9047619
> which.max(pred.prob)
167 
122 
> pred.prob[167]
      228 
0.8686869 
> pred.prob[122]
      167 
0.9047619 
> table(train$trial, pred.prob>0.5)
   
    FALSE TRUE
  0   614  116
  1   100  472
> (614+472)/(614+472+116+100)
[1] 0.8341014
> 472/(472+100)
[1] 0.8251748
> 614/(614+116)
[1] 0.8410959
> table(train$trial, pred.prob>=0.5)
   
    FALSE TRUE
  0   614  116
  1   100  472
> predTest = predict(trialCART, newdata=test)
> predTestProb = predTest[2]
> predTestProb = predTest[,2]
> table(test$trial, predTestProb>0.5)
   
    FALSE TRUE
  0   243   70
  1    71  174
> (243+174)/(243+174+70+71)
[1] 0.7473118
> table(test$trial, predTestProb>=0.5)
   
    FALSE TRUE
  0   243   70
  1    71  174
> library(ROCR)
Loading required package: gplots

Attaching package: gplots

The following object is masked from package:stats:

    lowess

> pred = prediction(predTest, test$trial)
Error in prediction(predTest, test$trial) : 
  Number of cross-validation runs must be equal for predictions and labels.
> pred = prediction(predTestProb, test$trial)
> as.numeric(performance(pred, "auc")@y.values)
[1] 0.7798526
> 
